HSPA5 | Human | (+)-pilocarpine | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Pilocarpine co-treated with Lithium] results in increased expression of HSPA5 mRNA more ... | CTD | PMID:21429313 |
HSPA5 | Human | (+)-schisandrin B | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of HSPA5 mRNA] | CTD | PMID:31150632 |
HSPA5 | Human | (+)-Tetrandrine | increases expression | EXP | | 6480464 | tetrandrine results in increased expression of HSPA5 protein | CTD | PMID:26822499 |
HSPA5 | Human | (-)-alpha-phellandrene | decreases expression | EXP | | 6480464 | alpha phellandrene results in decreased expression of HSPA5 mRNA | CTD | PMID:25075043 |
HSPA5 | Human | (-)-anisomycin | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Anisomycin results in decreased expression of HSPA5 mRNA and Anisomycin results in decreased expression of HSPA5 protein | CTD | PMID:25324550 |
HSPA5 | Human | (-)-gambogic acid | increases expression | EXP | | 6480464 | gambogic acid results in increased expression of HSPA5 protein | CTD | PMID:24291039 |
HSPA5 | Human | (-)-gambogic acid | multiple interactions | EXP | | 6480464 | Bortezomib promotes the reaction [gambogic acid results in increased expression of HSPA5 protein] and gambogic acid promotes the reaction [Bortezomib results in increased expression of HSPA5 protein] | CTD | PMID:24291039 |
HSPA5 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of HSPA5 mRNA | CTD | PMID:36331819 |
HSPA5 | Human | (E)-thiamethoxam | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Thiamethoxam results in increased expression of HSPA5 mRNA and Thiamethoxam results in increased expression of HSPA5 protein | CTD | PMID:33533595 |
HSPA5 | Human | (R)-adrenaline | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Epinephrine co-treated with Xanthine co-treated with XDH] results in increased expression of HSPA5 protein | CTD | PMID:19464573 |
HSPA5 | Human | (R)-lipoic acid | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of HSPA5 protein] | CTD | PMID:23892647 |
HSPA5 | Human | (R)-lipoic acid | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Thioctic Acid inhibits the reaction [cadmium acetate results in increased expression of HSPA5 protein] | CTD | PMID:30605698 |
HSPA5 | Human | (R)-noradrenaline | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Norepinephrine results in increased expression of HSPA5 mRNA and Norepinephrine results in increased expression of HSPA5 protein | CTD | PMID:16338971 |
HSPA5 | Human | (R,S)-Scoulerine | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [discretamine results in increased expression of HSPA5 protein] and Acetylcysteine inhibits the reaction [discretamine results in increased expression of HSPA5 protein] | CTD | PMID:32590070 |
HSPA5 | Human | (R,S)-Scoulerine | increases expression | EXP | | 6480464 | discretamine results in increased expression of HSPA5 protein | CTD | PMID:32590070 |
HSPA5 | Human | (S)-colchicine | increases expression | EXP | | 6480464 | Colchicine results in increased expression of HSPA5 protein | CTD | PMID:27358234 |
HSPA5 | Human | (S)-nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of HSPA5 | CTD | PMID:24201001 |
HSPA5 | Human | (S)-nicotine | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Nicotine inhibits the reaction [1-Methyl-4-phenyl-1 more ... | CTD | PMID:28082123 |
HSPA5 | Human | (S)-nicotine | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Nicotine inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HSPA5 protein] and Nicotine inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein] | CTD | PMID:18477628 and PMID:28082123 |
HSPA5 | Human | (Z)-3-butylidenephthalide | increases expression | EXP | | 6480464 | butylidenephthalide results in increased expression of HSPA5 protein | CTD | PMID:23770345 |
HSPA5 | Human | 1,2-dichloroethane | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of HSPA5 mRNA | CTD | PMID:28189721 and PMID:28960355 |
HSPA5 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | p-coumaric acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of HSPA5 protein] | CTD | PMID:29879413 |
HSPA5 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of HSPA5 mRNA] | CTD | PMID:22206623 |
HSPA5 | Human | 1,2-dimethylhydrazine | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of HSPA5 mRNA | CTD | PMID:22206623 |
HSPA5 | Human | 1,2-dimethylhydrazine | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of HSPA5 protein | CTD | PMID:29879413 |
HSPA5 | Human | 1,3-dinitrobenzene | increases metabolic processing | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 3-dinitrobenzene results in increased metabolism of HSPA5 protein | CTD | PMID:21402099 |
HSPA5 | Human | 1,4-dithiothreitol | increases expression | EXP | | 6480464 | Dithiothreitol metabolite results in increased expression of HSPA5 protein more ... | CTD | PMID:15710169 more ... |
HSPA5 | Human | 1,4-dithiothreitol | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Dithiothreitol metabolite results in increased expression of HSPA5 protein and Dithiothreitol results in increased expression of HSPA5 mRNA | CTD | PMID:17416481 and PMID:23123503 |
HSPA5 | Human | 1-bromopropane | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 1-bromopropane results in increased expression of HSPA5 protein | CTD | PMID:21925529 |
HSPA5 | Human | 1-bromopropane | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | 1-bromopropane results in increased expression of HSPA5 protein | CTD | PMID:27421776 |
HSPA5 | Human | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | 1-Methyl-4-phenyl-1 more ... | CTD | PMID:24140863 and PMID:28082123 |
HSPA5 | Human | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Nicotine inhibits the reaction [1-Methyl-4-phenyl-1 more ... | CTD | PMID:28082123 |
HSPA5 | Human | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | EXP | | 6480464 | TXN protein inhibits the reaction [1-Methyl-4-phenyl-1 more ... | CTD | PMID:24140863 |
HSPA5 | Human | 1-nitropyrene | multiple interactions | EXP | | 6480464 | Dicumarol inhibits the reaction [1-nitropyrene results in increased expression of HSPA5 protein] | CTD | PMID:19460413 |
HSPA5 | Human | 1-nitropyrene | increases expression | EXP | | 6480464 | 1-nitropyrene results in increased expression of HSPA5 protein | CTD | PMID:19460413 |
HSPA5 | Human | 15-acetyldeoxynivalenol | decreases expression | EXP | | 6480464 | 15-acetyldeoxynivalenol results in decreased expression of HSPA5 mRNA | CTD | PMID:20682335 |
HSPA5 | Human | 17alpha-ethynylestradiol | affects expression | ISO | Hspa5 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of HSPA5 mRNA | CTD | PMID:17555576 |
HSPA5 | Human | 17alpha-ethynylestradiol | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of HSPA5 mRNA | CTD | PMID:16174780 more ... |
HSPA5 | Human | 17alpha-ethynylestradiol | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in increased expression of HSPA5 mRNA | CTD | PMID:16174780 and PMID:19400957 |
HSPA5 | Human | 17alpha-ethynylestradiol | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol affects the expression of HSPA5 mRNA | CTD | PMID:20170705 |
HSPA5 | Human | 17alpha-ethynylestradiol | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HSPA5 mRNA | CTD | PMID:17942748 |
HSPA5 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with ESR1 protein] results in increased expression of HSPA5 protein more ... | CTD | PMID:19269315 more ... |
HSPA5 | Human | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of HSPA5 mRNA | CTD | PMID:23094148 |
HSPA5 | Human | 17beta-estradiol | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Estradiol results in increased expression of HSPA5 mRNA and Estradiol results in increased expression of HSPA5 protein | CTD | PMID:14664709 more ... |
HSPA5 | Human | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | affects localization | EXP | | 6480464 | Metribolone affects the localization of HSPA5 protein | CTD | PMID:17440980 |
HSPA5 | Human | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | EXP | | 6480464 | Metribolone results in increased expression of HSPA5 protein | CTD | PMID:17152098 |
HSPA5 | Human | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | multiple interactions | EXP | | 6480464 | Metribolone promotes the reaction [NDRG1 protein binds to HSPA5 protein] | CTD | PMID:17220478 |
HSPA5 | Human | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | EXP | | 6480464 | Dihydrotestosterone results in increased expression of HSPA5 mRNA | CTD | PMID:29581250 |
HSPA5 | Human | 1H-pyrazole | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | G6PDX affects the reaction [pyrazole results in increased expression of HSPA5 protein] and Vitamin E inhibits the reaction [pyrazole results in increased expression of HSPA5 protein] | CTD | PMID:18068688 |
HSPA5 | Human | 1H-pyrazole | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | pyrazole results in increased expression of HSPA5 mRNA and pyrazole results in increased expression of HSPA5 protein | CTD | PMID:12499123 more ... |
HSPA5 | Human | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:19095052 and PMID:22543052 |
HSPA5 | Human | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Hspa5 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30294300 |
HSPA5 | Human | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:30029115 |
HSPA5 | Human | 2,2,2-tetramine | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Trientine inhibits the reaction [Streptozocin results in decreased expression of HSPA5 protein] | CTD | PMID:19634143 |
HSPA5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HSPA5 mRNA | CTD | PMID:16039398 |
HSPA5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSPA5 protein | CTD | PMID:38437907 |
HSPA5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HSPA5 mRNA | CTD | PMID:33956508 and PMID:37318321 |
HSPA5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | EIF2S1 mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of HSPA5 protein] and salubrinal promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of HSPA5 protein] | CTD | PMID:24932542 |
HSPA5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSPA5 protein | CTD | PMID:12361703 and PMID:24932542 |
HSPA5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Hspa5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of HSPA5 mRNA | CTD | PMID:21570461 |
HSPA5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of HSPA5 mRNA | CTD | PMID:22298810 and PMID:34747641 |
HSPA5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HSPA5 mRNA and Tetrachlorodibenzodioxin results in decreased expression of HSPA5 protein | CTD | PMID:16548065 and PMID:32109520 |
HSPA5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HSPA5 mRNA | CTD | PMID:17942748 |
HSPA5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSPA5 mRNA | CTD | PMID:17942748 |
HSPA5 | Human | 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of HSPA5 protein] | CTD | PMID:30503585 |
HSPA5 | Human | 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of HSPA5 protein | CTD | PMID:30503585 |
HSPA5 | Human | 2,4,6-trinitrotoluene | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Trinitrotoluene affects the expression of HSPA5 mRNA | CTD | PMID:21346803 |
HSPA5 | Human | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:18550172 |
HSPA5 | Human | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:19954255 |
HSPA5 | Human | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:19954255 |
HSPA5 | Human | 2,4-dichlorophenol | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:27853103 |
HSPA5 | Human | 2,4-dichlorophenol | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:25160872 and PMID:27853103 |
HSPA5 | Human | 2,4-dichlorophenol | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | ursodoxicoltaurine inhibits the reaction [2 more ... | CTD | PMID:25160872 and PMID:27853103 |
HSPA5 | Human | 2,4-dinitrotoluene | increases expression | EXP | | 6480464 | 2 and 4-dinitrotoluene results in increased expression of HSPA5 mRNA | CTD | PMID:11409192 |
HSPA5 | Human | 2,6-dimethoxyphenol | multiple interactions | EXP | | 6480464 | [pyrogallol 1 more ... | CTD | PMID:38598786 |
HSPA5 | Human | 2-amino-2-deoxy-D-galactopyranose | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:28844859 |
HSPA5 | Human | 2-amino-2-deoxy-D-glucopyranose | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:20165829 and PMID:33812996 |
HSPA5 | Human | 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA] and 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 protein] | CTD | PMID:30602124 |
HSPA5 | Human | 2-amino-2-deoxy-D-glucopyranose | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Glucosamine results in increased expression of HSPA5 mRNA and Glucosamine results in increased expression of HSPA5 protein | CTD | PMID:30602124 |
HSPA5 | Human | 2-amino-2-deoxy-D-glucopyranose | increases expression | EXP | | 6480464 | Glucosamine results in increased expression of HSPA5 mRNA and Glucosamine results in increased expression of HSPA5 protein | CTD | PMID:15618547 more ... |
HSPA5 | Human | 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA] and ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA] | CTD | PMID:20165829 |
HSPA5 | Human | 2-amino-2-deoxy-D-glucopyranose | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Glucosamine results in increased expression of HSPA5 mRNA | CTD | PMID:20165829 |
HSPA5 | Human | 2-amino-2-deoxy-D-glucopyranose | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Glucosamine results in decreased expression of HSPA5 mRNA | CTD | PMID:17178593 |
HSPA5 | Human | 2-arachidonoylglycerol | increases expression | EXP | | 6480464 | glyceryl 2-arachidonate results in increased expression of HSPA5 mRNA | CTD | PMID:32357311 |
HSPA5 | Human | 2-deoxy-D-glucose | multiple interactions | EXP | | 6480464 | 4-Quinolones analog inhibits the reaction [Deoxyglucose results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:20593179 more ... |
HSPA5 | Human | 2-deoxy-D-glucose | increases expression | EXP | | 6480464 | Deoxyglucose results in increased expression of HSPA5 mRNA and Deoxyglucose results in increased expression of HSPA5 protein | CTD | PMID:20593179 and PMID:31022492 |
HSPA5 | Human | 2-hydroxypropanoic acid | multiple interactions | EXP | | 6480464 | HSPA5 protein affects the reaction [A2M protein modified form results in increased secretion of Lactic Acid] | CTD | PMID:25720493 |
HSPA5 | Human | 2-methyl-6-(phenylethynyl)pyridine | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Cocaine results in increased expression of HSPA5 protein] | CTD | PMID:17303341 |
HSPA5 | Human | 2-tert-butylhydroquinone | multiple interactions | EXP | | 6480464 | 2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased expression of HSPA5 protein] | CTD | PMID:25341683 |
HSPA5 | Human | 20-hydroxyecdysone | increases expression | EXP | | 6480464 | Ecdysterone results in increased expression of HSPA5 mRNA | CTD | PMID:29126784 |
HSPA5 | Human | 20-hydroxyecdysone | decreases expression | EXP | | 6480464 | Ecdysterone results in decreased expression of HSPA5 protein | CTD | PMID:29126784 |
HSPA5 | Human | 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Puromycin Aminonucleoside results in decreased expression of HSPA5 protein | CTD | PMID:19264907 |
HSPA5 | Human | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:37080397 |
HSPA5 | Human | 3,3'-diindolylmethane | decreases expression | EXP | | 6480464 | 3 and 3'-diindolylmethane analog results in decreased expression of HSPA5 protein | CTD | PMID:25794856 |
HSPA5 | Human | 3,3'-diindolylmethane | multiple interactions | EXP | | 6480464 | 3 and 3'-diindolylmethane analog promotes the reaction [HSPA5 protein affects the expression of and affects the activity of MMP9 protein] | CTD | PMID:25794856 |
HSPA5 | Human | 3-acetyldeoxynivalenol | decreases expression | EXP | | 6480464 | 3-acetyldeoxynivalenol results in decreased expression of HSPA5 mRNA | CTD | PMID:20682335 |
HSPA5 | Human | 3-acetyldeoxynivalenol | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of HSPA5 mRNA] | CTD | PMID:35413383 |
HSPA5 | Human | 3-acetyldeoxynivalenol | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | 3-acetyldeoxynivalenol results in increased expression of HSPA5 mRNA | CTD | PMID:35413383 |
HSPA5 | Human | 3-chloropropane-1,2-diol | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in decreased expression of HSPA5 protein | CTD | PMID:26597043 |
HSPA5 | Human | 3-methyladenine | multiple interactions | EXP | | 6480464 | 3-methyladenine promotes the reaction [Lipopolysaccharides results in increased expression of HSPA5 protein] and 3-methyladenine promotes the reaction [Potassium Dichromate results in increased expression of HSPA5 protein] | CTD | PMID:28245985 and PMID:32569804 |
HSPA5 | Human | 3-nitropropanoic acid | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 3-nitropropionic acid results in increased expression of HSPA5 protein | CTD | PMID:37116597 |
HSPA5 | Human | 3H-1,2-dithiole-3-thione | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | 1 and 2-dithiol-3-thione results in increased expression of HSPA5 mRNA | CTD | PMID:15302862 |
HSPA5 | Human | 3H-1,2-dithiole-3-thione | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 1 and 2-dithiol-3-thione results in decreased expression of HSPA5 mRNA | CTD | PMID:19162173 |
HSPA5 | Human | 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid | multiple interactions | EXP | | 6480464 | 4 more ... | CTD | PMID:29421517 |
HSPA5 | Human | 4,4'-sulfonyldiphenol | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | bisphenol S results in increased expression of HSPA5 mRNA | CTD | PMID:39298647 |
HSPA5 | Human | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of HSPA5 mRNA and bisphenol S results in increased expression of HSPA5 protein | CTD | PMID:34186270 and PMID:38134982 |
HSPA5 | Human | 4-hydroxy-TEMPO | multiple interactions | EXP | | 6480464 | tempol inhibits the reaction [PRKAA2 protein affects the expression of HSPA5 protein] | CTD | PMID:21145922 |
HSPA5 | Human | 4-hydroxynon-2-enal | affects binding | EXP | | 6480464 | 4-hydroxy-2-nonenal analog binds to HSPA5 | CTD | PMID:18232660 |
HSPA5 | Human | 4-hydroxynon-2-enal | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HSPA5 mRNA] | CTD | PMID:24291486 |
HSPA5 | Human | 4-hydroxynon-2-enal | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 4-hydroxy-2-nonenal results in increased expression of HSPA5 mRNA and 4-hydroxy-2-nonenal results in increased expression of HSPA5 protein | CTD | PMID:24291486 |
HSPA5 | Human | 4-hydroxyphenyl retinamide | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [Fenretinide results in increased expression of HSPA5 protein] | CTD | PMID:17353921 |
HSPA5 | Human | 4-hydroxyphenyl retinamide | increases expression | EXP | | 6480464 | Fenretinide results in increased expression of HSPA5 protein | CTD | PMID:17353921 and PMID:20546536 |
HSPA5 | Human | 4-hydroxyphenyl retinamide | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of HSPA5 mRNA | CTD | PMID:28973697 |
HSPA5 | Human | 4-hydroxyphenyl retinamide | decreases response to substance | EXP | | 6480464 | HSPA5 results in decreased susceptibility to Fenretinide | CTD | PMID:20546536 |
HSPA5 | Human | 4-phenylbutylamine | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 4-phenylbutylamine promotes the reaction [Zearalenone results in increased expression of HSPA5 protein] | CTD | PMID:30394307 |
HSPA5 | Human | 4-phenylbutyric acid | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-phenylbutyric acid inhibits the reaction [4-methyl-2 more ... | CTD | PMID:17459145 more ... |
HSPA5 | Human | 4-phenylbutyric acid | decreases expression | EXP | | 6480464 | 4-phenylbutyric acid results in decreased expression of HSPA5 protein | CTD | PMID:36005737 and PMID:36640941 |
HSPA5 | Human | 4-phenylbutyric acid | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | 4-phenylbutyric acid results in decreased expression of HSPA5 protein | CTD | PMID:28698385 |
HSPA5 | Human | 4-phenylbutyric acid | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 4-phenylbutyric acid results in decreased expression of HSPA5 protein | CTD | PMID:27484784 and PMID:28844859 |
HSPA5 | Human | 4-phenylbutyric acid | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [4-methyl-2 more ... | CTD | PMID:20165829 more ... |
HSPA5 | Human | 4-phenylbutyric acid | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [7 more ... | CTD | PMID:20165829 more ... |
HSPA5 | Human | 5-(N,N-hexamethylene)amiloride | affects expression | EXP | | 6480464 | 5-(N and N-hexamethylene)amiloride affects the expression of HSPA5 mRNA | CTD | PMID:19302589 |
HSPA5 | Human | 5-chloro-7-iodoquinolin-8-ol | decreases expression | EXP | | 6480464 | Clioquinol results in decreased expression of HSPA5 mRNA | CTD | PMID:36396104 |
HSPA5 | Human | 5-fluorouracil | decreases expression | EXP | | 6480464 | Fluorouracil results in decreased expression of HSPA5 mRNA and Fluorouracil results in decreased expression of HSPA5 protein | CTD | PMID:29879413 and PMID:32535746 |
HSPA5 | Human | 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 6-chloro-2 more ... | CTD | PMID:31433112 |
HSPA5 | Human | 6-propyl-2-thiouracil | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Propylthiouracil affects the expression of HSPA5 mRNA and Propylthiouracil affects the expression of HSPA5 protein | CTD | PMID:36038036 |
HSPA5 | Human | 7,12-dimethyltetraphene | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [9 more ... | CTD | PMID:22248470 |
HSPA5 | Human | 7,12-dimethyltetraphene | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 9 more ... | CTD | PMID:22248470 |
HSPA5 | Human | 7H-xanthine | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Epinephrine co-treated with Xanthine co-treated with XDH] results in increased expression of HSPA5 protein | CTD | PMID:19464573 |
HSPA5 | Human | 8-Br-cAMP | increases expression | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSPA5 mRNA | CTD | PMID:22079614 |
HSPA5 | Human | 9H-xanthine | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Epinephrine co-treated with Xanthine co-treated with XDH] results in increased expression of HSPA5 protein | CTD | PMID:19464573 |
HSPA5 | Human | abamectin | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | abamectin results in increased expression of HSPA5 mRNA | CTD | PMID:34748272 |
HSPA5 | Human | abamectin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Hesperidin inhibits the reaction [abamectin results in increased expression of HSPA5 mRNA] | CTD | PMID:34748272 |
HSPA5 | Human | acetylsalicylic acid | decreases expression | EXP | | 6480464 | Aspirin results in decreased expression of HSPA5 mRNA | CTD | PMID:14976132 |
HSPA5 | Human | aconitic acid | multiple interactions | EXP | | 6480464 | [Huang Qi co-treated with Coptidis rhizoma extract co-treated with Aconitic Acid co-treated with Centella asiatica extract] inhibits the reaction [[Sugars co-treated with TGFB1 protein] results in increased expression of HSPA5 protein] | CTD | PMID:38282657 |
HSPA5 | Human | aconitic acid | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Huang Qi co-treated with Coptidis rhizoma extract co-treated with Aconitic Acid co-treated with Centella asiatica extract] inhibits the reaction [[Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of HSPA5 mRNA] | CTD | PMID:38282657 |
HSPA5 | Human | acrolein | increases expression | EXP | | 6480464 | Acrolein results in increased expression of HSPA5 protein | CTD | PMID:18951912 |
HSPA5 | Human | acrolein | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Acrolein results in increased expression of HSPA5 protein | CTD | PMID:34813903 |
HSPA5 | Human | acrolein | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2 more ... | CTD | PMID:34813903 |
HSPA5 | Human | acrolein | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 3 more ... | CTD | PMID:29414845 |
HSPA5 | Human | acrolein | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Acrolein results in increased expression of HSPA5 mRNA and Acrolein results in increased expression of HSPA5 protein | CTD | PMID:28119953 and PMID:29414845 |
HSPA5 | Human | acrolein | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Acrolein results in decreased expression of HSPA5 mRNA | CTD | PMID:28482051 |
HSPA5 | Human | acrylamide | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Acrylamide results in increased expression of HSPA5 mRNA and Acrylamide results in increased expression of HSPA5 protein | CTD | PMID:33421551 more ... |
HSPA5 | Human | acrylamide | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [[INS co-treated with Acrylamide] results in increased expression of HSPA5 protein] more ... | CTD | PMID:38604440 and PMID:38740238 |
HSPA5 | Human | acrylonitrile | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Acrylonitrile results in increased expression of HSPA5 mRNA | CTD | PMID:35429547 |
HSPA5 | Human | actinomycin D | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Dactinomycin inhibits the reaction [Benzo(a)pyrene results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:17915553 |
HSPA5 | Human | actinomycin D | decreases expression | EXP | | 6480464 | Dactinomycin results in decreased expression of HSPA5 mRNA | CTD | PMID:34560123 |
HSPA5 | Human | actinomycin D | multiple interactions | EXP | | 6480464 | [Arsenic Trioxide co-treated with Dactinomycin] results in decreased expression of HSPA5 mRNA and [Arsenic Trioxide co-treated with Dactinomycin] results in increased expression of HSPA5 protein | CTD | PMID:34560123 |
HSPA5 | Human | aflatoxin B1 | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of HSPA5 mRNA | CTD | PMID:19770486 |
HSPA5 | Human | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of HSPA5 mRNA | CTD | PMID:27153756 |
HSPA5 | Human | agomelatine | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | agomelatine inhibits the reaction [Dietary Fats results in increased expression of HSPA5 protein] | CTD | PMID:34081941 |
HSPA5 | Human | alcohol | increases expression | EXP | | 401827866 | alcohol increases expression of HSPA5 protein in cardiomyocytes | RGD | |
HSPA5 | Human | aldehydo-D-glucosamine | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:20165829 and PMID:33812996 |
HSPA5 | Human | aldehydo-D-glucosamine | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Glucosamine results in increased expression of HSPA5 mRNA and Glucosamine results in increased expression of HSPA5 protein | CTD | PMID:30602124 |
HSPA5 | Human | aldehydo-D-glucosamine | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA] and 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 protein] | CTD | PMID:30602124 |
HSPA5 | Human | aldehydo-D-glucosamine | increases expression | EXP | | 6480464 | Glucosamine results in increased expression of HSPA5 mRNA and Glucosamine results in increased expression of HSPA5 protein | CTD | PMID:15618547 more ... |
HSPA5 | Human | aldehydo-D-glucosamine | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA] and ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA] | CTD | PMID:20165829 |
HSPA5 | Human | aldehydo-D-glucosamine | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Glucosamine results in increased expression of HSPA5 mRNA | CTD | PMID:20165829 |
HSPA5 | Human | aldehydo-D-glucosamine | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Glucosamine results in decreased expression of HSPA5 mRNA | CTD | PMID:17178593 |
HSPA5 | Human | aldehydo-D-glucose | increases expression | EXP | | 6480464 | Glucose deficiency results in increased expression of HSPA5 mRNA more ... | CTD | PMID:12147617 more ... |
HSPA5 | Human | aldehydo-D-glucose | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of HSPA5 protein] and Metformin inhibits the reaction [Glucose results in increased expression of HSPA5 protein] | CTD | PMID:34801538 |
HSPA5 | Human | aldehydo-D-glucose | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Glucose results in increased expression of HSPA5 mRNA and Glucose results in increased expression of HSPA5 protein | CTD | PMID:30076216 |
HSPA5 | Human | aldehydo-D-glucose | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 2-aminoethoxydiphenyl borate inhibits the reaction [Glucose results in increased expression of HSPA5 protein] more ... | CTD | PMID:21705745 and PMID:30076216 |
HSPA5 | Human | aldehydo-D-glucose | multiple interactions | EXP | | 6480464 | 4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:25451566 more ... |
HSPA5 | Human | aldehydo-D-glucose | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Glucose results in decreased expression of HSPA5 mRNA | CTD | PMID:24349266 |
HSPA5 | Human | aldehydo-D-glucose | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Glucose deficiency results in increased expression of HSPA5 protein and Glucose results in increased expression of HSPA5 protein | CTD | PMID:21337367 and PMID:34801538 |
HSPA5 | Human | aldehydo-D-glucose | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Glucose results in decreased expression of HSPA5 mRNA | CTD | PMID:17178593 |
HSPA5 | Human | Alisol B | increases expression | EXP | | 6480464 | alisol B results in increased expression of HSPA5 protein | CTD | PMID:20197400 |
HSPA5 | Human | all-trans-retinal | increases expression | EXP | | 6480464 | Retinaldehyde results in increased expression of HSPA5 protein | CTD | PMID:25331497 |
HSPA5 | Human | all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | MGAT5 protein inhibits the reaction [Tretinoin results in increased expression of HSPA5 protein] | CTD | PMID:17031849 |
HSPA5 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of HSPA5 mRNA | CTD | PMID:23724009 |
HSPA5 | Human | all-trans-retinoic acid | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Tretinoin results in increased expression of HSPA5 mRNA and Tretinoin results in increased expression of HSPA5 protein | CTD | PMID:22498432 |
HSPA5 | Human | all-trans-retinoic acid | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Tretinoin results in increased expression of HSPA5 mRNA | CTD | PMID:20488242 |
HSPA5 | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of HSPA5 mRNA and Tretinoin results in increased expression of HSPA5 protein | CTD | PMID:17031849 more ... |
HSPA5 | Human | allopurinol | increases expression | EXP | | 6480464 | Allopurinol results in increased expression of HSPA5 mRNA | CTD | PMID:32535746 |
HSPA5 | Human | alloxan | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Alloxan results in increased expression of HSPA5 mRNA | CTD | PMID:30076216 |
HSPA5 | Human | Aloe emodin | increases expression | EXP | | 6480464 | aloe emodin results in increased expression of HSPA5 mRNA and aloe emodin results in increased expression of HSPA5 protein | CTD | PMID:22210228 |
HSPA5 | Human | alpha-(methylamino)isobutyric acid | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 2-(methylamino)isobutyric acid inhibits the reaction [arsenite results in increased expression of HSPA5 mRNA] | CTD | PMID:22215663 |
HSPA5 | Human | alpha-D-galactose | multiple interactions | EXP | | 6480464 | Phycocyanin inhibits the reaction [Galactose results in increased expression of HSPA5 protein] | CTD | PMID:23036742 |
HSPA5 | Human | alpha-D-galactose | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Melatonin inhibits the reaction [Galactose results in increased expression of HSPA5 protein] | CTD | PMID:34673010 |
HSPA5 | Human | alpha-D-galactose | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Galactose results in increased expression of HSPA5 protein | CTD | PMID:34673010 |
HSPA5 | Human | alpha-D-galactose | increases expression | EXP | | 6480464 | Galactose results in increased expression of HSPA5 protein | CTD | PMID:23036742 |
HSPA5 | Human | alpha-phellandrene | decreases expression | EXP | | 6480464 | alpha phellandrene results in decreased expression of HSPA5 mRNA | CTD | PMID:25075043 |
HSPA5 | Human | amiloride | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Amiloride inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA] and Amiloride inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein] | CTD | PMID:20015086 |
HSPA5 | Human | amiodarone | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Amiodarone results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:25295624 |
HSPA5 | Human | amiodarone | increases expression | EXP | | 6480464 | Amiodarone results in increased expression of HSPA5 mRNA and Amiodarone results in increased expression of HSPA5 protein | CTD | PMID:25295624 and PMID:36586010 |
HSPA5 | Human | amiodarone | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 1-(3 and 4-dihydroxyphenyl)-2-thiocyanate-ethanone inhibits the reaction [Amiodarone results in increased expression of HSPA5 mRNA] | CTD | PMID:34259586 |
HSPA5 | Human | amiodarone | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Amiodarone results in increased expression of HSPA5 mRNA | CTD | PMID:34259586 |
HSPA5 | Human | ammonium chloride | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of HSPA5 mRNA | CTD | PMID:16483693 |
HSPA5 | Human | Ammothamnine | multiple interactions | EXP | | 6480464 | oxymatrine inhibits the reaction [sodium arsenite results in increased expression of HSPA5 mRNA] and oxymatrine inhibits the reaction [sodium arsenite results in increased expression of HSPA5 protein] | CTD | PMID:33241020 |
HSPA5 | Human | Ammothamnine | decreases expression | EXP | | 6480464 | oxymatrine results in decreased expression of HSPA5 mRNA | CTD | PMID:33241020 |
HSPA5 | Human | amosite asbestos | increases expression | EXP | | 6480464 | Asbestos more ... | CTD | PMID:23885834 |
HSPA5 | Human | amphibole asbestos | decreases expression | EXP | | 6480464 | Asbestos and Amphibole results in decreased expression of HSPA5 protein | CTD | PMID:20855422 |
HSPA5 | Human | aniline | increases nitrosation | ISO | Hspa5 (Rattus norvegicus) | 6480464 | aniline results in increased nitrosation of HSPA5 protein | CTD | PMID:21708182 |
HSPA5 | Human | anthra[1,9-cd]pyrazol-6(2H)-one | multiple interactions | EXP | | 6480464 | pyrazolanthrone inhibits the reaction [honokiol results in increased expression of HSPA5 protein] and pyrazolanthrone inhibits the reaction [Indomethacin results in increased expression of HSPA5 protein] | CTD | PMID:17341418 and PMID:33550458 |
HSPA5 | Human | anthra[1,9-cd]pyrazol-6(2H)-one | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | pyrazolanthrone inhibits the reaction [4-methyl-2 more ... | CTD | PMID:20920558 and PMID:33922211 |
HSPA5 | Human | antimony trichloride | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [arsenic trichloride co-treated with antimony trichloride] results in increased expression of HSPA5 protein more ... | CTD | PMID:34091186 |
HSPA5 | Human | antimony trichloride | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | antimony trichloride results in increased expression of HSPA5 mRNA and antimony trichloride results in increased expression of HSPA5 protein | CTD | PMID:34091186 |
HSPA5 | Human | antimony(0) | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Antimony results in increased expression of HSPA5 mRNA | CTD | PMID:37858840 |
HSPA5 | Human | antimycin A | increases expression | EXP | | 6480464 | Antimycin A results in increased expression of HSPA5 mRNA | CTD | PMID:33512557 |
HSPA5 | Human | antimycin A | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Antimycin A results in increased expression of HSPA5 protein | CTD | PMID:21337367 |
HSPA5 | Human | apigenin | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Apigenin inhibits the reaction [Brefeldin A results in increased expression of HSPA5 protein] and Apigenin inhibits the reaction [Thapsigargin results in increased expression of HSPA5 protein] | CTD | PMID:20493918 |
HSPA5 | Human | apigenin | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Apigenin results in decreased expression of HSPA5 mRNA | CTD | PMID:22359648 |
HSPA5 | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of HSPA5 | CTD | PMID:22445861 |
HSPA5 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of HSPA5 mRNA | CTD | PMID:33212167 |
HSPA5 | Human | Aroclor 1254 | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of HSPA5 mRNA | CTD | PMID:23650126 |
HSPA5 | Human | arsane | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Arsenic results in decreased expression of HSPA5 protein | CTD | PMID:22552367 |
HSPA5 | Human | arsane | multiple interactions | EXP | | 6480464 | [arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of HSPA5 mRNA and [Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in decreased expression of HSPA5 mRNA | CTD | PMID:35809665 |
HSPA5 | Human | arsane | affects expression | ISO | Hspa5 (Mus musculus) | 6480464 | Arsenic affects the expression of HSPA5 mRNA | CTD | PMID:36117518 |
HSPA5 | Human | arsane | increases expression | EXP | | 6480464 | Arsenic results in increased expression of HSPA5 protein | CTD | PMID:19818359 |
HSPA5 | Human | arsenic atom | increases expression | EXP | | 6480464 | Arsenic results in increased expression of HSPA5 protein | CTD | PMID:19818359 |
HSPA5 | Human | arsenic atom | multiple interactions | EXP | | 6480464 | [arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of HSPA5 mRNA and [Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in decreased expression of HSPA5 mRNA | CTD | PMID:35809665 |
HSPA5 | Human | arsenic atom | affects expression | ISO | Hspa5 (Mus musculus) | 6480464 | Arsenic affects the expression of HSPA5 mRNA | CTD | PMID:36117518 |
HSPA5 | Human | arsenic atom | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Arsenic results in decreased expression of HSPA5 protein | CTD | PMID:22552367 |
HSPA5 | Human | arsenic trichloride | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [arsenic trichloride co-treated with antimony trichloride] results in increased expression of HSPA5 protein | CTD | PMID:34091186 |
HSPA5 | Human | arsenic trichloride | multiple interactions | EXP | | 6480464 | [arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of HSPA5 mRNA and [Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in decreased expression of HSPA5 mRNA | CTD | PMID:35809665 |
HSPA5 | Human | arsenite(3-) | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | arsenite results in increased expression of HSPA5 mRNA | CTD | PMID:23123503 |
HSPA5 | Human | arsenite(3-) | increases expression | EXP | | 6480464 | arsenite results in increased expression of HSPA5 protein | CTD | PMID:22959463 and PMID:26677073 |
HSPA5 | Human | arsenite(3-) | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | arsenite results in increased expression of HSPA5 mRNA and arsenite results in increased expression of HSPA5 protein | CTD | PMID:22215663 more ... |
HSPA5 | Human | arsenite(3-) | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | arsenite results in decreased expression of HSPA5 mRNA | CTD | PMID:18929588 |
HSPA5 | Human | arsenite(3-) | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 2-(methylamino)isobutyric acid inhibits the reaction [arsenite results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:18929588 more ... |
HSPA5 | Human | arsenous acid | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Arsenic Trioxide results in increased expression of HSPA5 protein | CTD | PMID:21145380 |
HSPA5 | Human | arsenous acid | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Arsenic Trioxide results in increased expression of HSPA5 mRNA and Arsenic Trioxide results in increased expression of HSPA5 protein | CTD | PMID:21533816 more ... |
HSPA5 | Human | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of HSPA5 mRNA and Arsenic Trioxide results in increased expression of HSPA5 protein | CTD | PMID:11678611 more ... |
HSPA5 | Human | arsenous acid | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of HSPA5 mRNA | CTD | PMID:24356939 and PMID:25424538 |
HSPA5 | Human | arsenous acid | multiple interactions | EXP | | 6480464 | [Arsenic Trioxide co-treated with Dactinomycin] results in decreased expression of HSPA5 mRNA more ... | CTD | PMID:11678611 more ... |
HSPA5 | Human | arsenous acid | affects response to substance | EXP | | 6480464 | HSPA5 protein affects the susceptibility to Arsenic Trioxide | CTD | PMID:19695276 |
HSPA5 | Human | arsenous acid | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:21533816 more ... |
HSPA5 | Human | arsenous acid | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein] | CTD | PMID:21145380 |
HSPA5 | Human | atazanavir sulfate | decreases expression | EXP | | 6480464 | Atazanavir Sulfate results in decreased expression of HSPA5 mRNA | CTD | PMID:32152650 |
HSPA5 | Human | atazanavir sulfate | multiple interactions | EXP | | 6480464 | [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of HSPA5 mRNA | CTD | PMID:32152650 |
HSPA5 | Human | atorvastatin | multiple interactions | EXP | | 401827866 | atorvastatin inhibits the reaction [alcohol increases expression of HSPA5 protein in cardiomyocytes] | RGD | |
HSPA5 | Human | ATP | multiple interactions | EXP | | 6480464 | [Adenosine Triphosphate co-treated with Lipopolysaccharides] results in increased expression of HSPA5 mRNA more ... | CTD | PMID:24149798 |
HSPA5 | Human | atrazine | multiple interactions | EXP | | 6480464 | Atrazine promotes the reaction [arsenic trioxide results in increased expression of HSPA5 mRNA] | CTD | PMID:11678611 |
HSPA5 | Human | atrazine | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Atrazine affects the expression of HSPA5 mRNA | CTD | PMID:38056589 |
HSPA5 | Human | atrazine | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Atrazine results in increased expression of HSPA5 protein | CTD | PMID:38056589 |
HSPA5 | Human | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of HSPA5 mRNA | CTD | PMID:22378314 |
HSPA5 | Human | aucubin | multiple interactions | EXP | | 6480464 | aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of HSPA5 protein] | CTD | PMID:35961541 |
HSPA5 | Human | baicalein | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | baicalein inhibits the reaction [Carbon Tetrachloride results in increased expression of HSPA5 protein] | CTD | PMID:33779329 |
HSPA5 | Human | BAPTA | multiple interactions | EXP | | 6480464 | 1 more ... | CTD | PMID:28181380 |
HSPA5 | Human | Bardoxolone methyl | multiple interactions | EXP | | 6480464 | ochratoxin A promotes the reaction [bardoxolone methyl results in increased expression of HSPA5 protein] | CTD | PMID:36587836 |
HSPA5 | Human | Bardoxolone methyl | increases expression | EXP | | 6480464 | bardoxolone methyl results in increased expression of HSPA5 protein | CTD | PMID:35724838 and PMID:36587836 |
HSPA5 | Human | beauvericin | multiple interactions | EXP | | 6480464 | [beauvericin co-treated with enniatins] results in decreased expression of HSPA5 mRNA | CTD | PMID:31100301 |
HSPA5 | Human | benomyl | increases expression | EXP | | 6480464 | Benomyl results in increased expression of HSPA5 protein | CTD | PMID:27784618 |
HSPA5 | Human | benomyl | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Benomyl results in increased expression of HSPA5 protein] and MitoTEMPO inhibits the reaction [Benomyl results in increased expression of HSPA5 protein] | CTD | PMID:27784618 |
HSPA5 | Human | benzalkonium chloride | decreases expression | EXP | | 6480464 | Benzalkonium Compounds results in decreased expression of HSPA5 mRNA | CTD | PMID:28236482 |
HSPA5 | Human | benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of HSPA5 protein | CTD | PMID:12183065 |
HSPA5 | Human | benzo[a]pyrene | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of HSPA5 mRNA and Benzo(a)pyrene results in increased expression of HSPA5 protein | CTD | PMID:17915553 more ... |
HSPA5 | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of HSPA5 mRNA | CTD | PMID:21632981 and PMID:26238291 |
HSPA5 | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene metabolite results in increased expression of HSPA5 mRNA | CTD | PMID:24356939 |
HSPA5 | Human | benzo[a]pyrene | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of HSPA5 mRNA | CTD | PMID:19770486 and PMID:21715664 |
HSPA5 | Human | benzo[a]pyrene | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Dactinomycin inhibits the reaction [Benzo(a)pyrene results in increased expression of HSPA5 mRNA] | CTD | PMID:17915553 |
HSPA5 | Human | benzo[a]pyrene | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Benzo(a)pyrene results in increased expression of HSPA5 mRNA | CTD | PMID:17915553 |
HSPA5 | Human | benzo[a]pyrene diol epoxide I | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [7 more ... | CTD | PMID:35297523 |
HSPA5 | Human | benzo[a]pyrene diol epoxide I | increases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:35297523 |
HSPA5 | Human | beta-cyclodextrin | multiple interactions | EXP | | 6480464 | betadex inhibits the reaction [Lipopolysaccharides results in increased expression of HSPA5 protein] and betadex inhibits the reaction [SREBF2 protein results in increased expression of HSPA5 protein] | CTD | PMID:33677747 |
HSPA5 | Human | beta-D-glucosamine | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:20165829 and PMID:33812996 |
HSPA5 | Human | beta-D-glucosamine | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA] and 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 protein] | CTD | PMID:30602124 |
HSPA5 | Human | beta-D-glucosamine | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Glucosamine results in increased expression of HSPA5 mRNA and Glucosamine results in increased expression of HSPA5 protein | CTD | PMID:30602124 |
HSPA5 | Human | beta-D-glucosamine | increases expression | EXP | | 6480464 | Glucosamine results in increased expression of HSPA5 mRNA and Glucosamine results in increased expression of HSPA5 protein | CTD | PMID:15618547 more ... |
HSPA5 | Human | beta-D-glucosamine | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA] and ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA] | CTD | PMID:20165829 |
HSPA5 | Human | beta-D-glucosamine | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Glucosamine results in increased expression of HSPA5 mRNA | CTD | PMID:20165829 |
HSPA5 | Human | beta-D-glucosamine | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Glucosamine results in decreased expression of HSPA5 mRNA | CTD | PMID:17178593 |
HSPA5 | Human | beta-naphthoflavone | increases expression | EXP | | 6480464 | beta-Naphthoflavone results in increased expression of HSPA5 mRNA | CTD | PMID:19737606 |
HSPA5 | Human | bifenthrin | increases expression | EXP | | 6480464 | bifenthrin results in increased expression of HSPA5 protein | CTD | PMID:16271832 |
HSPA5 | Human | bilirubin IXalpha | increases expression | EXP | | 6480464 | Bilirubin results in increased expression of HSPA5 mRNA and Bilirubin results in increased expression of HSPA5 protein | CTD | PMID:20196124 and PMID:27578021 |
HSPA5 | Human | bilirubin IXalpha | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Bilirubin inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of HSPA5 mRNA] | CTD | PMID:37054934 |
HSPA5 | Human | bilirubin IXalpha | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Bilirubin results in increased expression of HSPA5 mRNA] and Bilirubin inhibits the reaction [[Cannabidiol co-treated with Rotenone] results in increased expression of HSPA5 mRNA] | CTD | PMID:27578021 and PMID:32033040 |
HSPA5 | Human | bis(2-chloroethyl) sulfide | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Mustard Gas results in increased expression of HSPA5 mRNA | CTD | PMID:15674843 |
HSPA5 | Human | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of HSPA5 protein | CTD | PMID:16400681 |
HSPA5 | Human | bis(2-ethylhexyl) phthalate | affects expression | ISO | Hspa5 (Mus musculus) | 6480464 | Diethylhexyl Phthalate affects the expression of HSPA5 mRNA | CTD | PMID:33754040 |
HSPA5 | Human | bis(2-ethylhexyl) phthalate | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of HSPA5 mRNA | CTD | PMID:34319233 |
HSPA5 | Human | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of HSPA5 mRNA and [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of HSPA5 protein | CTD | PMID:37364641 |
HSPA5 | Human | bis(2-ethylhexyl) phthalate | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Diethylhexyl Phthalate results in increased expression of GRP78 protein and Diethylhexyl Phthalate results in increased expression of HSPA5 mRNA | CTD | PMID:21318169 more ... |
HSPA5 | Human | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of HSPA5 mRNA | CTD | PMID:21318169 |
HSPA5 | Human | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of HSPA5 mRNA | CTD | PMID:20170705 and PMID:30903817 |
HSPA5 | Human | bisphenol A | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 18alpha-glycyrrhetinic acid inhibits the reaction [bisphenol A results in increased expression of HSPA5 mRNA] | CTD | PMID:35699857 |
HSPA5 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of HSPA5 protein | CTD | PMID:34186270 |
HSPA5 | Human | bisphenol A | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of HSPA5 mRNA | CTD | PMID:30903817 |
HSPA5 | Human | bisphenol A | increases methylation | ISO | Hspa5 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of HSPA5 gene | CTD | PMID:28505145 |
HSPA5 | Human | bisphenol A | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of HSPA5 mRNA | CTD | PMID:30816183 more ... |
HSPA5 | Human | bisphenol A | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of HSPA5 protein | CTD | PMID:21705745 and PMID:36613676 |
HSPA5 | Human | bisphenol A | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of HSPA5 mRNA more ... | CTD | PMID:21705745 more ... |
HSPA5 | Human | bisphenol A | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of HSPA5 mRNA and bisphenol A results in increased expression of HSPA5 protein | CTD | PMID:22649256 more ... |
HSPA5 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of HSPA5 mRNA and bisphenol A results in increased expression of HSPA5 protein | CTD | PMID:25333893 more ... |
HSPA5 | Human | bisphenol A | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | bisphenol A results in increased expression of HSPA5 mRNA and bisphenol A results in increased expression of HSPA5 protein | CTD | PMID:12233820 more ... |
HSPA5 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with ESR1 protein] results in increased expression of HSPA5 protein | CTD | PMID:19269315 |
HSPA5 | Human | bisphenol AF | increases expression | EXP | | 6480464 | bisphenol AF results in increased expression of HSPA5 protein | CTD | PMID:34186270 |
HSPA5 | Human | Bisphenol B | increases expression | EXP | | 6480464 | bisphenol B results in increased expression of HSPA5 protein | CTD | PMID:34186270 |
HSPA5 | Human | bisphenol F | increases expression | EXP | | 6480464 | bisphenol F results in increased expression of HSPA5 mRNA and bisphenol F results in increased expression of HSPA5 protein | CTD | PMID:34186270 and PMID:38134982 |
HSPA5 | Human | bisphenol F | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | bisphenol F results in increased expression of HSPA5 mRNA | CTD | PMID:35387338 and PMID:38685157 |
HSPA5 | Human | bleomycin A2 | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Bleomycin results in increased expression of HSPA5 protein | CTD | PMID:25933445 and PMID:37163307 |
HSPA5 | Human | bleomycin A2 | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | pachymic acid inhibits the reaction [Bleomycin results in increased expression of HSPA5 protein] | CTD | PMID:37163307 |
HSPA5 | Human | boric acid | increases expression | EXP | | 6480464 | boric acid results in increased expression of HSPA5 mRNA and boric acid results in increased expression of HSPA5 protein | CTD | PMID:25425213 and PMID:27587023 |
HSPA5 | Human | bortezomib | multiple interactions | EXP | | 6480464 | Bortezomib inhibits the reaction [Brefeldin A results in increased expression of HSPA5 protein] more ... | CTD | PMID:15141013 more ... |
HSPA5 | Human | bortezomib | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Bortezomib results in increased expression of HSPA5 mRNA | CTD | PMID:15509775 |
HSPA5 | Human | bortezomib | decreases response to substance | EXP | | 6480464 | HSPA5 results in decreased susceptibility to Bortezomib | CTD | PMID:20546536 |
HSPA5 | Human | bortezomib | increases expression | EXP | | 6480464 | Bortezomib results in increased expression of HSPA5 more ... | CTD | PMID:15141013 more ... |
HSPA5 | Human | brefeldin A | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Acetylcysteine inhibits the reaction [Brefeldin A results in increased expression of HSPA5 protein] more ... | CTD | PMID:20493918 |
HSPA5 | Human | brefeldin A | increases expression | EXP | | 6480464 | Brefeldin A results in increased expression of HSPA5 mRNA and Brefeldin A results in increased expression of HSPA5 protein | CTD | PMID:12147617 more ... |
HSPA5 | Human | brefeldin A | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Brefeldin A results in increased expression of HSPA5 protein | CTD | PMID:20493918 |
HSPA5 | Human | brefeldin A | multiple interactions | EXP | | 6480464 | Bortezomib inhibits the reaction [Brefeldin A results in increased expression of HSPA5 protein] and Brefeldin A inhibits the reaction [Shiga toxin subunit A results in increased cleavage of HSPA5 protein] | CTD | PMID:18723477 and PMID:33483759 |
HSPA5 | Human | bromoacetate | increases expression | EXP | | 6480464 | bromoacetate results in increased expression of HSPA5 mRNA | CTD | PMID:19753638 |
HSPA5 | Human | bromobenzene | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | bromobenzene results in decreased expression of HSPA5 mRNA | CTD | PMID:15056800 |
HSPA5 | Human | bromobenzene | affects binding | ISO | Hspa5 (Rattus norvegicus) | 6480464 | bromobenzene metabolite binds to HSPA5 protein | CTD | PMID:12018992 |
HSPA5 | Human | bromobenzene | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | bromobenzene results in increased expression of HSPA5 mRNA | CTD | PMID:12628495 |
HSPA5 | Human | bufalin | decreases expression | EXP | | 6480464 | bufalin results in decreased expression of HSPA5 mRNA | CTD | PMID:27444971 |
HSPA5 | Human | bupropion | increases expression | EXP | | 6480464 | Bupropion results in increased expression of HSPA5 protein | CTD | PMID:21354251 |
HSPA5 | Human | buspirone | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Buspirone results in decreased expression of HSPA5 mRNA | CTD | PMID:24136188 |
HSPA5 | Human | busulfan | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Busulfan results in increased expression of HSPA5 protein | CTD | PMID:35533795 |
HSPA5 | Human | busulfan | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Busulfan results in increased expression of HSPA5 protein] | CTD | PMID:35533795 |
HSPA5 | Human | Butylbenzyl phthalate | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of HSPA5 mRNA and [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of HSPA5 protein | CTD | PMID:37364641 |
HSPA5 | Human | Butylparaben | increases expression | EXP | | 6480464 | butylparaben results in increased expression of HSPA5 protein | CTD | PMID:29319206 |
HSPA5 | Human | Butylparaben | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | butylparaben results in increased expression of HSPA5 mRNA | CTD | PMID:36277366 |
HSPA5 | Human | butyric acid | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [Butyric Acid results in increased expression of HSPA5 protein] and Plicamycin inhibits the reaction [Butyric Acid results in increased expression of HSPA5 protein] | CTD | PMID:26784903 |
HSPA5 | Human | butyric acid | increases expression | EXP | | 6480464 | Butyric Acid results in increased expression of HSPA5 protein | CTD | PMID:26784903 |
HSPA5 | Human | cadmium acetate | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Chloroquine promotes the reaction [cadmium acetate results in increased expression of HSPA5 protein] more ... | CTD | PMID:29870746 more ... |
HSPA5 | Human | cadmium acetate | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | cadmium acetate results in increased expression of HSPA5 protein | CTD | PMID:29870746 more ... |
HSPA5 | Human | cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of HSPA5 mRNA and Cadmium results in increased expression of HSPA5 protein | CTD | PMID:16020198 more ... |
HSPA5 | Human | cadmium atom | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSPA5 protein | CTD | PMID:37261864 |
HSPA5 | Human | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride co-treated with Cadmium] results in increased expression of HSPA5 protein more ... | CTD | PMID:33040242 more ... |
HSPA5 | Human | cadmium dichloride | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Cadmium Chloride results in increased expression of HSPA5 mRNA and Cadmium Chloride results in increased expression of HSPA5 protein | CTD | PMID:15081267 more ... |
HSPA5 | Human | cadmium dichloride | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 protein]] more ... | CTD | PMID:31433112 |
HSPA5 | Human | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of HSPA5 protein | CTD | PMID:24419708 and PMID:26220685 |
HSPA5 | Human | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride co-treated with Cadmium] results in increased expression of HSPA5 protein more ... | CTD | PMID:25374377 more ... |
HSPA5 | Human | cadmium dichloride | affects expression | EXP | | 6480464 | Cadmium Chloride affects the expression of HSPA5 mRNA | CTD | PMID:23828170 |
HSPA5 | Human | cadmium dichloride | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:15081267 more ... |
HSPA5 | Human | cadmium dichloride | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased expression of HSPA5 mRNA and Cadmium Chloride results in increased expression of HSPA5 protein | CTD | PMID:18636176 more ... |
HSPA5 | Human | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of HSPA5 mRNA and Cadmium Chloride results in increased expression of HSPA5 protein | CTD | PMID:18560533 more ... |
HSPA5 | Human | cadmium sulfate | increases expression | EXP | | 6480464 | cadmium sulfate results in increased expression of HSPA5 mRNA | CTD | PMID:12064557 |
HSPA5 | Human | Calcimycin | increases expression | EXP | | 6480464 | Calcimycin results in increased expression of HSPA5 mRNA and Calcimycin results in increased expression of HSPA5 protein | CTD | PMID:12147617 more ... |
HSPA5 | Human | Calcimycin | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Calcimycin results in increased expression of HSPA5 mRNA and Calcimycin results in increased expression of HSPA5 protein | CTD | PMID:14610226 and PMID:18799549 |
HSPA5 | Human | Calcimycin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [Calcimycin results in increased expression of HSPA5 mRNA] and Quercetin inhibits the reaction [Calcimycin results in increased expression of HSPA5 protein] | CTD | PMID:19428936 |
HSPA5 | Human | calcitriol | multiple interactions | EXP | | 6480464 | [Calcitriol co-treated with salinomycin] results in increased expression of HSPA5 mRNA and Calcitriol promotes the reaction [salinomycin results in increased expression of HSPA5 mRNA] | CTD | PMID:35914560 |
HSPA5 | Human | calcium atom | multiple interactions | EXP | | 6480464 | [DNAJB11 protein binds to HSPA5 protein] which results in decreased transport of Calcium more ... | CTD | PMID:26085089 |
HSPA5 | Human | calcium atom | decreases transport | EXP | | 6480464 | HSPA5 protein results in decreased transport of Calcium | CTD | PMID:26085089 |
HSPA5 | Human | calcium(0) | multiple interactions | EXP | | 6480464 | [DNAJB11 protein binds to HSPA5 protein] which results in decreased transport of Calcium more ... | CTD | PMID:26085089 |
HSPA5 | Human | calcium(0) | decreases transport | EXP | | 6480464 | HSPA5 protein results in decreased transport of Calcium | CTD | PMID:26085089 |
HSPA5 | Human | calix[6]arene | increases expression | EXP | | 6480464 | calix(6)arene results in increased expression of HSPA5 protein | CTD | PMID:23872419 |
HSPA5 | Human | Candesartan cilexetil | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | candesartan cilexetil results in decreased expression of HSPA5 protein | CTD | PMID:22120037 |
HSPA5 | Human | cannabidiol | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Cannabidiol co-treated with Rotenone] results in increased expression of HSPA5 mRNA and Bilirubin inhibits the reaction [[Cannabidiol co-treated with Rotenone] results in increased expression of HSPA5 mRNA] | CTD | PMID:32033040 |
HSPA5 | Human | cannabidiol | increases expression | EXP | | 6480464 | Cannabidiol results in increased expression of HSPA5 mRNA and Cannabidiol results in increased expression of HSPA5 protein | CTD | PMID:28025562 more ... |
HSPA5 | Human | cantharidin | increases expression | EXP | | 6480464 | Cantharidin results in increased expression of HSPA5 protein | CTD | PMID:27113412 and PMID:35398186 |
HSPA5 | Human | cantharidin | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Cantharidin results in increased expression of HSPA5 protein | CTD | PMID:35398186 |
HSPA5 | Human | cantharidin | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Cantharidin results in increased expression of HSPA5 protein] | CTD | PMID:35398186 |
HSPA5 | Human | capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of HSPA5 and Capsaicin results in increased expression of HSPA5 protein | CTD | PMID:19139269 more ... |
HSPA5 | Human | capsaicin | increases localization | EXP | | 6480464 | Capsaicin results in increased localization of HSPA5 protein | CTD | PMID:19331147 |
HSPA5 | Human | captan | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Captan results in increased expression of HSPA5 protein | CTD | PMID:34303901 |
HSPA5 | Human | carbaryl | increases expression | EXP | | 6480464 | Carbaryl results in increased expression of HSPA5 mRNA | CTD | PMID:11226373 and PMID:27829164 |
HSPA5 | Human | carbon atom | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides]] which results in increased expression of HSPA5 mRNA and [Air Pollutants results in increased abundance of Carbon] which results in increased expression of HSPA5 mRNA | CTD | PMID:31268311 |
HSPA5 | Human | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:22157353 and PMID:30138652 |
HSPA5 | Human | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes and Carbon results in decreased expression of HSPA5 mRNA | CTD | PMID:30802478 |
HSPA5 | Human | carbon nanotube | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25620056 |
HSPA5 | Human | carboplatin | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Carboplatin results in decreased expression of HSPA5 mRNA | CTD | PMID:18172885 |
HSPA5 | Human | casticin | increases expression | EXP | | 6480464 | casticin results in increased expression of HSPA5 protein | CTD | PMID:27862857 |
HSPA5 | Human | celastrol | increases expression | EXP | | 6480464 | celastrol results in increased expression of HSPA5 mRNA | CTD | PMID:17010675 |
HSPA5 | Human | celecoxib | increases expression | EXP | | 6480464 | Celecoxib results in increased expression of HSPA5 | CTD | PMID:21567098 |
HSPA5 | Human | ceruletide | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Ceruletide results in decreased expression of HSPA5 protein | CTD | PMID:18024178 |
HSPA5 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to HSPA5 gene] | CTD | PMID:28238834 |
HSPA5 | Human | chenodeoxycholic acid | multiple interactions | EXP | | 6480464 | [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of HSPA5 mRNA more ... | CTD | PMID:32152650 |
HSPA5 | Human | Chikusetsusaponin-V | multiple interactions | EXP | | 6480464 | chikusetsusaponin V inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HSPA5 protein] | CTD | PMID:25073091 |
HSPA5 | Human | chlordecone | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Chlordecone co-treated with fulvestrant] results in increased expression of HSPA5 protein more ... | CTD | PMID:17640991 |
HSPA5 | Human | chlordecone | increases response to substance | ISO | Hspa5 (Mus musculus) | 6480464 | HSPA5 protein results in increased susceptibility to Chlordecone | CTD | PMID:17640991 |
HSPA5 | Human | chlordecone | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Chlordecone results in increased expression of HSPA5 mRNA and Chlordecone results in increased expression of HSPA5 protein | CTD | PMID:17640991 |
HSPA5 | Human | chlorhexidine | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Chlorhexidine results in increased expression of HSPA5 protein | CTD | PMID:19027770 |
HSPA5 | Human | chlormequat chloride | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Chlormequat results in increased expression of HSPA5 protein] | CTD | PMID:34958886 |
HSPA5 | Human | chlormequat chloride | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Chlormequat results in increased expression of HSPA5 protein | CTD | PMID:34958886 |
HSPA5 | Human | chloroacetaldehyde | decreases expression | EXP | | 6480464 | chloroacetaldehyde results in decreased expression of HSPA5 mRNA | CTD | PMID:25596134 |
HSPA5 | Human | chloroacetic acid | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | chloroacetic acid results in increased expression of HSPA5 mRNA and chloroacetic acid results in increased expression of HSPA5 protein | CTD | PMID:25451595 |
HSPA5 | Human | chloroacetic acid | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Acetylcysteine inhibits the reaction [chloroacetic acid results in increased expression of HSPA5 protein] more ... | CTD | PMID:25451595 |
HSPA5 | Human | Chloroacetonitrile | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | chloroacetonitrile results in increased expression of HSPA5 protein | CTD | PMID:36940772 |
HSPA5 | Human | chlorobenzene | increases expression | EXP | | 6480464 | chlorobenzene results in increased expression of HSPA5 protein | CTD | PMID:12183065 |
HSPA5 | Human | chloroethene | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Vinyl Chloride results in increased expression of HSPA5 mRNA | CTD | PMID:31445928 |
HSPA5 | Human | chlorogenic acid | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Chlorogenic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of HSPA5 protein] and Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of HSPA5 protein] | CTD | PMID:34801538 |
HSPA5 | Human | chlorophyllin | increases expression | EXP | | 6480464 | chlorophyllin analog results in increased expression of HSPA5 protein | CTD | PMID:22852132 |
HSPA5 | Human | chloropicrin | increases expression | EXP | | 6480464 | chloropicrin results in increased expression of HSPA5 protein | CTD | PMID:22516760 |
HSPA5 | Human | chloroquine | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Chloroquine promotes the reaction [cadmium acetate results in increased expression of HSPA5 protein] | CTD | PMID:29870746 |
HSPA5 | Human | chlorpyrifos | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of HSPA5 mRNA | CTD | PMID:22515965 |
HSPA5 | Human | chlorpyrifos | increases methylation | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Chlorpyrifos results in increased methylation of HSPA5 gene | CTD | PMID:32905263 |
HSPA5 | Human | chlorpyrifos | increases expression | EXP | | 6480464 | Chlorpyrifos results in increased expression of HSPA5 protein | CTD | PMID:27993609 |
HSPA5 | Human | chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of HSPA5 mRNA | CTD | PMID:25424538 |
HSPA5 | Human | choline | affects expression | EXP | | 6480464 | Choline affects the expression of HSPA5 mRNA | CTD | PMID:17616785 |
HSPA5 | Human | choline | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HSPA5 protein more ... | CTD | PMID:20938992 more ... |
HSPA5 | Human | chromium(6+) | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of HSPA5 protein | CTD | PMID:30974164 |
HSPA5 | Human | chromium(6+) | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [chromium hexavalent ion results in increased expression of HSPA5 protein] and [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of HSPA5 mRNA | CTD | PMID:38479592 and PMID:38992767 |
HSPA5 | Human | chromium(6+) | increases expression | EXP | | 6480464 | chromium hexavalent ion results in increased expression of HSPA5 protein | CTD | PMID:30416085 and PMID:38992767 |
HSPA5 | Human | chrysazin | increases expression | EXP | | 6480464 | danthron results in increased expression of HSPA5 protein | CTD | PMID:21126053 |
HSPA5 | Human | cidofovir anhydrous | decreases expression | EXP | | 6480464 | Cidofovir results in decreased expression of HSPA5 mRNA | CTD | PMID:25596134 |
HSPA5 | Human | cimetidine | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Cimetidine inhibits the reaction [Ethanol results in increased expression of HSPA5 protein] | CTD | PMID:27983966 |
HSPA5 | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with Quercetin] results in increased expression of HSPA5 mRNA more ... | CTD | PMID:27234046 more ... |
HSPA5 | Human | cisplatin | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Linagliptin inhibits the reaction [Cisplatin results in increased expression of HSPA5 mRNA] | CTD | PMID:32567747 |
HSPA5 | Human | cisplatin | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Cisplatin results in increased expression of HSPA5 mRNA and Cisplatin results in increased expression of HSPA5 protein | CTD | PMID:32567747 and PMID:38688426 |
HSPA5 | Human | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of HSPA5 mRNA | CTD | PMID:11099651 more ... |
HSPA5 | Human | cisplatin | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Cisplatin results in increased expression of HSPA5 mRNA and Cisplatin results in increased expression of HSPA5 protein | CTD | PMID:23603837 and PMID:37561086 |
HSPA5 | Human | cisplatin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Cisplatin co-treated with isoliquiritigenin] results in increased expression of HSPA5 mRNA more ... | CTD | PMID:23603837 and PMID:37561086 |
HSPA5 | Human | cisplatin | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Cisplatin affects the expression of HSPA5 protein | CTD | PMID:20071420 |
HSPA5 | Human | cisplatin | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Cisplatin results in decreased expression of HSPA5 mRNA | CTD | PMID:21151649 |
HSPA5 | Human | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of HSPA5 mRNA and Cisplatin results in increased expression of HSPA5 protein | CTD | PMID:16357177 and PMID:19561079 |
HSPA5 | Human | clofibrate | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of HSPA5 mRNA | CTD | PMID:17585979 |
HSPA5 | Human | clofibrate | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Clofibrate results in decreased expression of HSPA5 mRNA | CTD | PMID:21318169 |
HSPA5 | Human | cobalt dichloride | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | cobaltous chloride results in increased expression of HSPA5 protein | CTD | PMID:21337367 |
HSPA5 | Human | cobicistat | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:33629115 |
HSPA5 | Human | cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of HSPA5 mRNA | CTD | PMID:15009677 |
HSPA5 | Human | cocaine | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Cocaine results in increased expression of HSPA5 mRNA and Cocaine results in increased expression of HSPA5 protein | CTD | PMID:17303341 and PMID:23644055 |
HSPA5 | Human | cocaine | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Cocaine results in increased expression of HSPA5 protein] more ... | CTD | PMID:17303341 |
HSPA5 | Human | colforsin daropate hydrochloride | increases response to substance | EXP | | 6480464 | HSPA5 protein results in increased susceptibility to Colforsin | CTD | PMID:22912664 |
HSPA5 | Human | copper atom | multiple interactions | EXP | | 6480464 | [Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in decreased expression of HSPA5 mRNA and [NSC 689534 binds to Copper] which results in increased expression of HSPA5 mRNA | CTD | PMID:20971185 and PMID:35809665 |
HSPA5 | Human | copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of HSPA5 protein | CTD | PMID:15836927 and PMID:22692975 |
HSPA5 | Human | copper atom | affects binding | EXP | | 6480464 | HSPA5 protein binds to Copper | CTD | PMID:14534351 and PMID:15359738 |
HSPA5 | Human | copper(0) | multiple interactions | EXP | | 6480464 | [Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in decreased expression of HSPA5 mRNA and [NSC 689534 binds to Copper] which results in increased expression of HSPA5 mRNA | CTD | PMID:20971185 and PMID:35809665 |
HSPA5 | Human | copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of HSPA5 protein | CTD | PMID:15836927 and PMID:22692975 |
HSPA5 | Human | copper(0) | affects binding | EXP | | 6480464 | HSPA5 protein binds to Copper | CTD | PMID:14534351 and PMID:15359738 |
HSPA5 | Human | copper(II) chloride | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of HSPA5 mRNA more ... | CTD | PMID:20920558 |
HSPA5 | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of HSPA5 mRNA | CTD | PMID:19549813 |
HSPA5 | Human | copper(II) sulfate | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Copper Sulfate results in increased expression of HSPA5 protein | CTD | PMID:37353053 |
HSPA5 | Human | copper(II) sulfate | affects localization | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Copper Sulfate affects the localization of HSPA5 protein | CTD | PMID:21815057 |
HSPA5 | Human | corilagin | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | corilagin inhibits the reaction [Morphine results in increased expression of HSPA5 protein] and TLR2 protein inhibits the reaction [corilagin inhibits the reaction [Morphine results in increased expression of HSPA5 protein]] | CTD | PMID:37394652 |
HSPA5 | Human | crocidolite asbestos | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in increased expression of HSPA5 protein | CTD | PMID:24918270 |
HSPA5 | Human | crocidolite asbestos | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | OGG1 protein mutant form promotes the reaction [Asbestos and Crocidolite results in increased expression of HSPA5 protein] | CTD | PMID:24918270 |
HSPA5 | Human | curcumin | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Curcumin results in decreased expression of HSPA5 protein] more ... | CTD | PMID:27996348 and PMID:36640941 |
HSPA5 | Human | curcumin | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Curcumin inhibits the reaction [bis(2-ethylhexyl) 2 more ... | CTD | PMID:34784780 |
HSPA5 | Human | curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of HSPA5 mRNA | CTD | PMID:29723631 |
HSPA5 | Human | curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of HSPA5 protein | CTD | PMID:36640941 |
HSPA5 | Human | curcumin | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Curcumin results in increased expression of HSPA5 mRNA | CTD | PMID:18200517 |
HSPA5 | Human | cyanocob(III)alamin | multiple interactions | EXP | | 6480464 | [Vitamin B 6 co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of HSPA5 protein] | CTD | PMID:37263574 |
HSPA5 | Human | cyanocob(III)alamin | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Vitamin B 6 co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of HSPA5 protein] | CTD | PMID:37263574 |
HSPA5 | Human | cyanocob(III)alamin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Vitamin B 12 inhibits the reaction [Streptozocin results in increased expression of HSPA5 protein] | CTD | PMID:38049026 |
HSPA5 | Human | cycloheximide | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Cycloheximide inhibits the reaction [GIF 0010 results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:17915553 and PMID:9742210 |
HSPA5 | Human | cycloheximide | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein] more ... | CTD | PMID:26784903 more ... |
HSPA5 | Human | cyclophosphamide | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Cyclophosphamide results in decreased expression of HSPA5 mRNA | CTD | PMID:11906922 |
HSPA5 | Human | cyclophosphamide | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Cyclophosphamide results in increased expression of HSPA5 protein | CTD | PMID:38740238 |
HSPA5 | Human | cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide metabolite results in increased expression of HSPA5 mRNA | CTD | PMID:24356939 |
HSPA5 | Human | cyclosporin A | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Cyclosporine results in increased expression of HSPA5 mRNA and Cyclosporine results in increased expression of HSPA5 protein | CTD | PMID:22155090 more ... |
HSPA5 | Human | cyclosporin A | multiple interactions | EXP | | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of HSPA5 mRNA | CTD | PMID:32152650 |
HSPA5 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of HSPA5 mRNA and Cyclosporine results in increased expression of HSPA5 protein | CTD | PMID:19159671 more ... |
HSPA5 | Human | cyclosporin A | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 2-dimethylamino-4 more ... | CTD | PMID:22155090 |
HSPA5 | Human | cyclosporin A | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Melatonin promotes the reaction [Cyclosporine results in increased expression of HSPA5 protein] | CTD | PMID:20136702 |
HSPA5 | Human | cyclosporin A | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Cyclosporine results in increased expression of HSPA5 mRNA and Cyclosporine results in increased expression of HSPA5 protein | CTD | PMID:20136702 more ... |
HSPA5 | Human | cyfluthrin | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | cyfluthrin results in increased expression of HSPA5 mRNA and cyfluthrin results in increased expression of HSPA5 protein | CTD | PMID:36548566 |
HSPA5 | Human | cylindrospermopsin | decreases expression | EXP | | 6480464 | cylindrospermopsin results in decreased expression of HSPA5 mRNA | CTD | PMID:24921660 |
HSPA5 | Human | cypermethrin | decreases expression | EXP | | 6480464 | cypermethrin results in decreased expression of HSPA5 mRNA | CTD | PMID:25424538 |
HSPA5 | Human | cypermethrin | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | cypermethrin results in increased expression of HSPA5 mRNA | CTD | PMID:35876585 |
HSPA5 | Human | cytochalasin B | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Cytochalasin B results in increased expression of HSPA5 protein | CTD | PMID:26732598 |
HSPA5 | Human | D-glucose | increases expression | EXP | | 6480464 | Glucose deficiency results in increased expression of HSPA5 mRNA more ... | CTD | PMID:12147617 more ... |
HSPA5 | Human | D-glucose | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of HSPA5 protein] and Metformin inhibits the reaction [Glucose results in increased expression of HSPA5 protein] | CTD | PMID:34801538 |
HSPA5 | Human | D-glucose | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Glucose results in increased expression of HSPA5 mRNA and Glucose results in increased expression of HSPA5 protein | CTD | PMID:30076216 |
HSPA5 | Human | D-glucose | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 2-aminoethoxydiphenyl borate inhibits the reaction [Glucose results in increased expression of HSPA5 protein] more ... | CTD | PMID:21705745 and PMID:30076216 |
HSPA5 | Human | D-glucose | multiple interactions | EXP | | 6480464 | 4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:25451566 more ... |
HSPA5 | Human | D-glucose | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Glucose results in decreased expression of HSPA5 mRNA | CTD | PMID:24349266 |
HSPA5 | Human | D-glucose | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Glucose deficiency results in increased expression of HSPA5 protein and Glucose results in increased expression of HSPA5 protein | CTD | PMID:21337367 and PMID:34801538 |
HSPA5 | Human | D-glucose | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Glucose results in decreased expression of HSPA5 mRNA | CTD | PMID:17178593 |
HSPA5 | Human | D-mannopyranose | multiple interactions | EXP | | 6480464 | Mannose inhibits the reaction [Deoxyglucose results in increased expression of HSPA5 protein] | CTD | PMID:20593179 |
HSPA5 | Human | D-penicillamine | increases expression | EXP | | 6480464 | Penicillamine results in increased expression of HSPA5 protein | CTD | PMID:19722195 and PMID:22843330 |
HSPA5 | Human | D-penicillamine | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Penicillamine promotes the reaction [ATP7B protein mutant form results in decreased expression of HSPA5 protein] | CTD | PMID:22945834 |
HSPA5 | Human | dantrolene | multiple interactions | EXP | | 6480464 | Dantrolene inhibits the reaction [tributyltin results in increased expression of HSPA5 protein] | CTD | PMID:23743301 |
HSPA5 | Human | dapagliflozin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | dapagliflozin inhibits the reaction [IL1B protein results in increased expression of HSPA5 mRNA] | CTD | PMID:37741535 |
HSPA5 | Human | DDE | decreases expression | EXP | | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of HSPA5 mRNA | CTD | PMID:38568856 |
HSPA5 | Human | DDT | increases expression | EXP | | 6480464 | DDT results in increased expression of HSPA5 mRNA | CTD | PMID:15710169 |
HSPA5 | Human | DDT | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | DDT results in increased expression of HSPA5 mRNA | CTD | PMID:29477483 |
HSPA5 | Human | demethoxycurcumin | multiple interactions | EXP | | 6480464 | demethoxycurcumin analog inhibits the reaction [Thapsigargin results in increased expression of HSPA5 protein] | CTD | PMID:26264395 |
HSPA5 | Human | deoxycholic acid | decreases response to substance | EXP | | 6480464 | HSPA5 protein results in decreased susceptibility to Deoxycholic Acid | CTD | PMID:12507930 |
HSPA5 | Human | deoxycholic acid | multiple interactions | EXP | | 6480464 | [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of HSPA5 mRNA more ... | CTD | PMID:32152650 |
HSPA5 | Human | deoxynivalenol | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | calpain inhibitor III inhibits the reaction [deoxynivalenol results in increased degradation of HSPA5 protein] more ... | CTD | PMID:10652249 and PMID:19336499 |
HSPA5 | Human | deoxynivalenol | increases phosphorylation | ISO | Hspa5 (Mus musculus) | 6480464 | deoxynivalenol results in increased phosphorylation of HSPA5 protein | CTD | PMID:23811945 |
HSPA5 | Human | deoxynivalenol | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | deoxynivalenol results in decreased expression of HSPA5 mRNA | CTD | PMID:10652249 |
HSPA5 | Human | deoxynivalenol | decreases expression | EXP | | 6480464 | deoxynivalenol results in decreased expression of HSPA5 mRNA | CTD | PMID:20682335 and PMID:24356939 |
HSPA5 | Human | Di-n-octyl phthalate | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of HSPA5 mRNA and [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of HSPA5 protein | CTD | PMID:37364641 |
HSPA5 | Human | diallyl trisulfide | decreases expression | EXP | | 6480464 | diallyl trisulfide results in decreased expression of HSPA5 protein | CTD | PMID:19550292 |
HSPA5 | Human | diamminedichloroplatinum | decreases expression | EXP | | 6480464 | transplatin results in decreased expression of HSPA5 mRNA | CTD | PMID:11099651 |
HSPA5 | Human | diarsenic trioxide | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of HSPA5 mRNA | CTD | PMID:24356939 and PMID:25424538 |
HSPA5 | Human | diarsenic trioxide | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Arsenic Trioxide results in increased expression of HSPA5 protein | CTD | PMID:21145380 |
HSPA5 | Human | diarsenic trioxide | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:21533816 more ... |
HSPA5 | Human | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of HSPA5 mRNA and Arsenic Trioxide results in increased expression of HSPA5 protein | CTD | PMID:11678611 more ... |
HSPA5 | Human | diarsenic trioxide | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein] | CTD | PMID:21145380 |
HSPA5 | Human | diarsenic trioxide | multiple interactions | EXP | | 6480464 | [Arsenic Trioxide co-treated with Dactinomycin] results in decreased expression of HSPA5 mRNA more ... | CTD | PMID:11678611 more ... |
HSPA5 | Human | diarsenic trioxide | affects response to substance | EXP | | 6480464 | HSPA5 protein affects the susceptibility to Arsenic Trioxide | CTD | PMID:19695276 |
HSPA5 | Human | diarsenic trioxide | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Arsenic Trioxide results in increased expression of HSPA5 mRNA and Arsenic Trioxide results in increased expression of HSPA5 protein | CTD | PMID:21533816 more ... |
HSPA5 | Human | diazinon | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Diazinon results in increased expression of HSPA5 protein | CTD | PMID:19647006 |
HSPA5 | Human | diazinon | decreases expression | EXP | | 6480464 | Diazinon results in decreased expression of HSPA5 mRNA | CTD | PMID:24356939 |
HSPA5 | Human | Dibromoacetonitrile | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | dibromoacetonitrile results in increased expression of HSPA5 protein | CTD | PMID:38065397 |
HSPA5 | Human | Dibromoacetonitrile | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [dibromoacetonitrile results in increased expression of HSPA5 protein] and Acetylcysteine inhibits the reaction [dibromoacetonitrile results in increased expression of HSPA5 protein] | CTD | PMID:38065397 |
HSPA5 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of HSPA5 mRNA | CTD | PMID:37042841 |
HSPA5 | Human | dibutyl phthalate | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of HSPA5 protein | CTD | PMID:26804720 |
HSPA5 | Human | dibutyl phthalate | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in increased expression of HSPA5 protein | CTD | PMID:26804720 |
HSPA5 | Human | dibutyl phthalate | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of HSPA5 protein] more ... | CTD | PMID:26804720 and PMID:37364641 |
HSPA5 | Human | dibutyl phthalate | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of HSPA5 protein] | CTD | PMID:26804720 |
HSPA5 | Human | dichlorine | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of HSPA5 mRNA | CTD | PMID:18636392 |
HSPA5 | Human | diclofenac | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Diclofenac results in increased expression of HSPA5 mRNA | CTD | PMID:25014874 |
HSPA5 | Human | diclofenac | increases expression | EXP | | 6480464 | Diclofenac results in increased expression of HSPA5 mRNA | CTD | PMID:27313093 |
HSPA5 | Human | diclofenac | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Diclofenac co-treated with lipopolysaccharide and E coli O55-B5] results in increased expression of HSPA5 protein | CTD | PMID:25772430 |
HSPA5 | Human | dicoumarol | multiple interactions | EXP | | 6480464 | Dicumarol inhibits the reaction [1-nitropyrene results in increased expression of HSPA5 protein] | CTD | PMID:19460413 |
HSPA5 | Human | Dienochlor | decreases expression | EXP | | 6480464 | dienochlor results in decreased expression of HSPA5 protein | CTD | PMID:16884889 |
HSPA5 | Human | diethyl maleate | decreases reduction | ISO | Hspa5 (Mus musculus) | 6480464 | diethyl maleate results in decreased reduction of HSPA5 protein | CTD | PMID:19843705 |
HSPA5 | Human | diethyl phthalate | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of HSPA5 mRNA and [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of HSPA5 protein | CTD | PMID:37364641 |
HSPA5 | Human | dihydrocapsaicin | increases expression | EXP | | 6480464 | dihydrocapsaicin results in increased expression of HSPA5 protein | CTD | PMID:19139269 |
HSPA5 | Human | Diisodecyl phthalate | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of HSPA5 mRNA and [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of HSPA5 protein | CTD | PMID:37364641 |
HSPA5 | Human | diisononyl phthalate | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of HSPA5 mRNA and [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of HSPA5 protein | CTD | PMID:37364641 |
HSPA5 | Human | dimethylarsinic acid | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Cacodylic Acid results in increased expression of HSPA5 mRNA | CTD | PMID:16122865 |
HSPA5 | Human | Dinitramine | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | dinitramine results in increased expression of HSPA5 protein | CTD | PMID:33288293 |
HSPA5 | Human | dioscin | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | dioscin inhibits the reaction [Ethanol results in increased expression of HSPA5 protein] | CTD | PMID:24146112 |
HSPA5 | Human | dioscin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | dioscin inhibits the reaction [Ethanol results in increased expression of HSPA5 protein] | CTD | PMID:24146112 |
HSPA5 | Human | dioxygen | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 4-chlorobenzyltetrahydroberberine inhibits the reaction [Oxygen deficiency results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:22226148 |
HSPA5 | Human | dioxygen | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Oxygen deficiency results in decreased expression of HSPA5 protein | CTD | PMID:25937538 |
HSPA5 | Human | dioxygen | affects expression | EXP | | 6480464 | Oxygen deficiency affects the expression of HSPA5 mRNA | CTD | PMID:25596134 |
HSPA5 | Human | dioxygen | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Oxygen deficiency results in increased expression of HSPA5 protein | CTD | PMID:24680926 |
HSPA5 | Human | dioxygen | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Oxygen deficiency results in increased expression of HSPA5 mRNA and Oxygen deficiency results in increased expression of HSPA5 protein | CTD | PMID:21337367 and PMID:22226148 |
HSPA5 | Human | dioxygen | multiple interactions | EXP | | 6480464 | Oxygen deficiency inhibits the reaction [Deoxyglucose results in increased expression of HSPA5 protein] | CTD | PMID:20593179 |
HSPA5 | Human | disodium selenite | increases expression | EXP | | 6480464 | Sodium Selenite results in increased expression of HSPA5 protein | CTD | PMID:28161410 |
HSPA5 | Human | diuron | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Diuron results in decreased expression of HSPA5 mRNA | CTD | PMID:21551480 |
HSPA5 | Human | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of HSPA5 mRNA | CTD | PMID:35967413 |
HSPA5 | Human | dizocilpine maleate | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Dizocilpine Maleate inhibits the reaction [Cocaine results in increased expression of HSPA5 protein] | CTD | PMID:17303341 |
HSPA5 | Human | dopamine | increases expression | EXP | | 6480464 | Dopamine results in increased expression of HSPA5 protein | CTD | PMID:24675778 |
HSPA5 | Human | dorsomorphin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | dorsomorphin inhibits the reaction [4-methyl-2 more ... | CTD | PMID:31433112 more ... |
HSPA5 | Human | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of HSPA5 mRNA | CTD | PMID:17680992 and PMID:29803840 |
HSPA5 | Human | doxorubicin | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Doxorubicin results in decreased expression of HSPA5 mRNA | CTD | PMID:30261314 |
HSPA5 | Human | doxorubicin | affects expression | EXP | | 6480464 | Doxorubicin affects the expression of HSPA5 protein | CTD | PMID:29385562 |
HSPA5 | Human | doxorubicin | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Doxorubicin results in increased expression of HSPA5 protein | CTD | PMID:28495616 more ... |
HSPA5 | Human | doxorubicin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [Doxorubicin results in increased expression of HSPA5 protein] more ... | CTD | PMID:28495616 more ... |
HSPA5 | Human | doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin inhibits the reaction [Thapsigargin results in increased expression of HSPA5 protein] | CTD | PMID:16298333 |
HSPA5 | Human | edaravone | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Edaravone promotes the reaction [[Pilocarpine co-treated with Lithium] results in increased expression of HSPA5 protein] | CTD | PMID:21429313 |
HSPA5 | Human | elaidic acid | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Acrylamide promotes the reaction [elaidic acid results in increased expression of HSPA5 protein]] more ... | CTD | PMID:38740238 |
HSPA5 | Human | elaidic acid | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | elaidic acid results in increased expression of HSPA5 protein | CTD | PMID:38740238 |
HSPA5 | Human | elemental carbon | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides]] which results in increased expression of HSPA5 mRNA and [Air Pollutants results in increased abundance of Carbon] which results in increased expression of HSPA5 mRNA | CTD | PMID:31268311 |
HSPA5 | Human | emodin | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Emodin results in increased expression of HSPA5 protein | CTD | PMID:19549930 |
HSPA5 | Human | empagliflozin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | empagliflozin inhibits the reaction [Rotenone results in increased expression of HSPA5 protein] | CTD | PMID:35654124 |
HSPA5 | Human | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of HSPA5 protein | CTD | PMID:16884889 |
HSPA5 | Human | endosulfan | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of HSPA5 mRNA and Endosulfan results in increased expression of HSPA5 protein | CTD | PMID:31464424 |
HSPA5 | Human | endosulfan | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Endosulfan affects the expression of HSPA5 mRNA | CTD | PMID:29391264 |
HSPA5 | Human | enniatin | multiple interactions | EXP | | 6480464 | [beauvericin co-treated with enniatins] results in decreased expression of HSPA5 mRNA | CTD | PMID:31100301 |
HSPA5 | Human | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HSPA5 protein | CTD | PMID:23301498 |
HSPA5 | Human | epoxiconazole | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of HSPA5 mRNA | CTD | PMID:35436446 |
HSPA5 | Human | erastin | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | erastin promotes the reaction [Silicon Dioxide results in increased expression of HSPA5 protein] | CTD | PMID:37075931 |
HSPA5 | Human | erastin | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | erastin results in increased expression of HSPA5 protein | CTD | PMID:37075931 |
HSPA5 | Human | ethanol | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Cimetidine inhibits the reaction [Ethanol results in increased expression of HSPA5 protein] more ... | CTD | PMID:24146112 more ... |
HSPA5 | Human | ethanol | affects expression | ISO | Hspa5 (Mus musculus) | 6480464 | Ethanol affects the expression of HSPA5 mRNA | CTD | PMID:30319688 |
HSPA5 | Human | ethanol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Ethanol results in increased expression of HSPA5 protein] | CTD | PMID:24224909 |
HSPA5 | Human | ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of HSPA5 protein | CTD | PMID:24224909 |
HSPA5 | Human | ethanol | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Ethanol results in decreased expression of HSPA5 protein | CTD | PMID:23200777 and PMID:24646710 |
HSPA5 | Human | ethanol | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Ethanol results in increased expression of HSPA5 mRNA and Ethanol results in increased expression of HSPA5 protein | CTD | PMID:24146112 and PMID:28119953 |
HSPA5 | Human | ethanol | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | dioscin inhibits the reaction [Ethanol results in increased expression of HSPA5 protein] | CTD | PMID:24146112 |
HSPA5 | Human | ethanol | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Ethanol results in increased expression of HSPA5 mRNA and Ethanol results in increased expression of HSPA5 protein | CTD | PMID:24146112 more ... |
HSPA5 | Human | ethylbenzene | increases expression | EXP | | 6480464 | ethylbenzene results in increased expression of HSPA5 protein | CTD | PMID:12183065 |
HSPA5 | Human | ethylene glycol | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Ethylene Glycol results in increased expression of HSPA5 mRNA | CTD | PMID:34468068 |
HSPA5 | Human | ethylene glycol | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | caryophyllene inhibits the reaction [Ethylene Glycol results in increased expression of HSPA5 mRNA] | CTD | PMID:34468068 |
HSPA5 | Human | ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Egtazic Acid co-treated with Paraoxon] results in increased expression of HSPA5 protein | CTD | PMID:26998625 |
HSPA5 | Human | fangchinoline | increases expression | EXP | | 6480464 | fangchinoline results in increased expression of HSPA5 protein | CTD | PMID:28754437 |
HSPA5 | Human | fangchinoline | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [fangchinoline results in increased expression of HSPA5 protein] | CTD | PMID:28754437 |
HSPA5 | Human | fenofibrate | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Fenofibrate results in decreased expression of HSPA5 mRNA | CTD | PMID:25596134 |
HSPA5 | Human | fenofibrate | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Fenofibrate inhibits the reaction [Dietary Fats results in increased expression of HSPA5 protein] | CTD | PMID:38216941 |
HSPA5 | Human | fenvalerate | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | fenvalerate affects the expression of HSPA5 protein | CTD | PMID:33656234 |
HSPA5 | Human | ferrostatin-1 | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | ferrostatin-1 results in increased expression of HSPA5 protein | CTD | PMID:37075931 |
HSPA5 | Human | fisetin | multiple interactions | EXP | | 6480464 | 1 more ... | CTD | PMID:28181380 |
HSPA5 | Human | fisetin | increases expression | EXP | | 6480464 | fisetin results in increased expression of HSPA5 protein | CTD | PMID:28181380 |
HSPA5 | Human | flavokawain B | increases expression | EXP | | 6480464 | flavokawain B results in increased expression of HSPA5 protein | CTD | PMID:30025493 |
HSPA5 | Human | fluoranthene | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of HSPA5 mRNA | CTD | PMID:28329830 |
HSPA5 | Human | fluorescein 5-isothiocyanate | affects binding | EXP | | 6480464 | Fluorescein-5-isothiocyanate binds to HSPA5 protein | CTD | PMID:27129696 |
HSPA5 | Human | flutamide | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Flutamide results in increased expression of HSPA5 mRNA and Flutamide results in increased expression of HSPA5 protein | CTD | PMID:32662666 |
HSPA5 | Human | folic acid | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HSPA5 protein more ... | CTD | PMID:20938992 more ... |
HSPA5 | Human | folic acid | multiple interactions | EXP | | 6480464 | [Vitamin B 6 co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of HSPA5 protein] | CTD | PMID:37263574 |
HSPA5 | Human | folic acid | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of HSPA5 mRNA | CTD | PMID:25629700 |
HSPA5 | Human | folic acid | decreases expression | EXP | | 6480464 | Folic Acid deficiency results in decreased expression of HSPA5 protein | CTD | PMID:28639913 |
HSPA5 | Human | formetanate | increases expression | EXP | | 6480464 | formetanate results in increased expression of HSPA5 protein | CTD | PMID:16271832 |
HSPA5 | Human | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of HSPA5 protein | CTD | PMID:37730182 |
HSPA5 | Human | fructose | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Fructose results in increased expression of HSPA5 mRNA and Fructose results in increased expression of HSPA5 protein | CTD | PMID:22698815 |
HSPA5 | Human | fructose | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of HSPA5 protein more ... | CTD | PMID:34801538 |
HSPA5 | Human | fructose | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Phenylbutyrates inhibits the reaction [Fructose results in increased expression of HSPA5 protein] | CTD | PMID:22698815 |
HSPA5 | Human | fulvestrant | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Chlordecone co-treated with fulvestrant] results in increased expression of HSPA5 protein | CTD | PMID:17640991 |
HSPA5 | Human | fumonisin B1 | increases expression | EXP | | 6480464 | fumonisin B1 results in increased expression of HSPA5 mRNA and fumonisin B1 results in increased expression of HSPA5 protein | CTD | PMID:31891755 |
HSPA5 | Human | fumonisin B1 | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [fumonisin B1 results in increased expression of HSPA5 protein] and thermozymocidin inhibits the reaction [fumonisin B1 results in increased expression of HSPA5 protein] | CTD | PMID:31891755 |
HSPA5 | Human | furan | affects binding | ISO | Hspa5 (Rattus norvegicus) | 6480464 | furan binds to HSPA5 protein | CTD | PMID:22240984 |
HSPA5 | Human | furan | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | rhodioloside inhibits the reaction [furan results in increased expression of HSPA5 mRNA] and rhodioloside inhibits the reaction [furan results in increased expression of HSPA5 protein] | CTD | PMID:34450210 |
HSPA5 | Human | furan | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | furan results in increased expression of HSPA5 mRNA and furan results in increased expression of HSPA5 protein | CTD | PMID:34450210 |
HSPA5 | Human | furan | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | furan results in decreased expression of HSPA5 mRNA | CTD | PMID:26194646 |
HSPA5 | Human | furazolidone | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Furazolidone results in increased expression of HSPA5 protein] | CTD | PMID:27996348 |
HSPA5 | Human | furazolidone | increases expression | EXP | | 6480464 | Furazolidone results in increased expression of HSPA5 protein | CTD | PMID:27996348 |
HSPA5 | Human | furfural | multiple interactions | EXP | | 6480464 | [pyrogallol 1 more ... | CTD | PMID:38598786 |
HSPA5 | Human | Fusarenone X | decreases expression | EXP | | 6480464 | fusarenon-X results in decreased expression of HSPA5 mRNA | CTD | PMID:20682335 |
HSPA5 | Human | gadolinium atom | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Gadolinium inhibits the reaction [Glucose results in increased expression of HSPA5 protein] | CTD | PMID:30076216 |
HSPA5 | Human | gadolinium trichloride | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | gadolinium chloride results in increased expression of HSPA5 protein | CTD | PMID:21198628 |
HSPA5 | Human | gadolinium trichloride | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Acetylcysteine inhibits the reaction [gadolinium chloride results in increased expression of HSPA5 protein] | CTD | PMID:21198628 |
HSPA5 | Human | gadolinium trichloride | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | gadolinium chloride affects the expression of HSPA5 mRNA | CTD | PMID:21198628 |
HSPA5 | Human | galactose | multiple interactions | EXP | | 6480464 | Phycocyanin inhibits the reaction [Galactose results in increased expression of HSPA5 protein] | CTD | PMID:23036742 |
HSPA5 | Human | galactose | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Melatonin inhibits the reaction [Galactose results in increased expression of HSPA5 protein] | CTD | PMID:34673010 |
HSPA5 | Human | galactose | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Galactose results in increased expression of HSPA5 protein | CTD | PMID:34673010 |
HSPA5 | Human | galactose | increases expression | EXP | | 6480464 | Galactose results in increased expression of HSPA5 protein | CTD | PMID:23036742 |
HSPA5 | Human | gallium nitrate | decreases expression | EXP | | 6480464 | gallium nitrate results in decreased expression of HSPA5 mRNA | CTD | PMID:18586083 |
HSPA5 | Human | gedunin | increases expression | EXP | | 6480464 | gedunin results in increased expression of HSPA5 mRNA | CTD | PMID:17010675 |
HSPA5 | Human | geldanamycin | multiple interactions | EXP | | 6480464 | Bortezomib promotes the reaction [geldanamycin results in increased expression of HSPA5 protein] and geldanamycin promotes the reaction [Bortezomib results in increased expression of HSPA5 protein] | CTD | PMID:15141013 |
HSPA5 | Human | geldanamycin | increases expression | EXP | | 6480464 | geldanamycin results in increased expression of HSPA5 protein | CTD | PMID:15141013 |
HSPA5 | Human | geldanamycin | affects expression | EXP | | 6480464 | geldanamycin affects the expression of HSPA5 protein | CTD | PMID:14576064 |
HSPA5 | Human | gemcitabine | increases expression | EXP | | 6480464 | Gemcitabine results in increased expression of HSPA5 mRNA | CTD | PMID:17039268 |
HSPA5 | Human | gentamycin | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of HSPA5 mRNA and Gentamicins results in increased expression of HSPA5 protein | CTD | PMID:17567590 more ... |
HSPA5 | Human | gentamycin | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | ursodoxicoltaurine inhibits the reaction [Gentamicins results in increased expression of HSPA5 mRNA] and ursodoxicoltaurine inhibits the reaction [Gentamicins results in increased expression of HSPA5 protein] | CTD | PMID:29751043 |
HSPA5 | Human | gentamycin | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Gentamicins results in increased expression of HSPA5 mRNA and Gentamicins results in increased expression of HSPA5 protein | CTD | PMID:29751043 |
HSPA5 | Human | ginsenoside Rg1 | multiple interactions | EXP | | 6480464 | ginsenoside Rg1 inhibits the reaction [Lipopolysaccharides results in increased expression of HSPA5 protein] | CTD | PMID:30918470 |
HSPA5 | Human | glafenine | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Glafenine results in increased expression of HSPA5 mRNA | CTD | PMID:24136188 |
HSPA5 | Human | Glucogallin | multiple interactions | EXP | | 6480464 | glucogallin inhibits the reaction [Glucose results in increased expression of HSPA5 protein] | CTD | PMID:25451566 |
HSPA5 | Human | glucose | increases expression | EXP | | 6480464 | Glucose deficiency results in increased expression of HSPA5 mRNA more ... | CTD | PMID:12147617 more ... |
HSPA5 | Human | glucose | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of HSPA5 protein] and Metformin inhibits the reaction [Glucose results in increased expression of HSPA5 protein] | CTD | PMID:34801538 |
HSPA5 | Human | glucose | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Glucose results in increased expression of HSPA5 mRNA and Glucose results in increased expression of HSPA5 protein | CTD | PMID:30076216 |
HSPA5 | Human | glucose | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 2-aminoethoxydiphenyl borate inhibits the reaction [Glucose results in increased expression of HSPA5 protein] more ... | CTD | PMID:21705745 and PMID:30076216 |
HSPA5 | Human | glucose | multiple interactions | EXP | | 6480464 | 4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:25451566 more ... |
HSPA5 | Human | glucose | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Glucose results in decreased expression of HSPA5 mRNA | CTD | PMID:24349266 |
HSPA5 | Human | glucose | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Glucose deficiency results in increased expression of HSPA5 protein and Glucose results in increased expression of HSPA5 protein | CTD | PMID:21337367 and PMID:34801538 |
HSPA5 | Human | glucose | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Glucose results in decreased expression of HSPA5 mRNA | CTD | PMID:17178593 |
HSPA5 | Human | glutathione | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Glutathione inhibits the reaction [Brefeldin A results in increased expression of HSPA5 protein] and Glutathione inhibits the reaction [Thapsigargin results in increased expression of HSPA5 protein] | CTD | PMID:20493918 |
HSPA5 | Human | glycine | multiple interactions | EXP | | 6480464 | Glycine inhibits the reaction [Homocysteine results in increased expression of HSPA5 mRNA] | CTD | PMID:27064126 |
HSPA5 | Human | glycine betaine | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Betaine results in decreased expression of HSPA5 mRNA | CTD | PMID:22945834 |
HSPA5 | Human | glycochenodeoxycholic acid | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Glycochenodeoxycholic Acid co-treated with Scopoletin] results in increased expression of HSPA5 mRNA | CTD | PMID:34979142 |
HSPA5 | Human | glycochenodeoxycholic acid | multiple interactions | EXP | | 6480464 | [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of HSPA5 mRNA more ... | CTD | PMID:32152650 |
HSPA5 | Human | glycocholic acid | multiple interactions | EXP | | 6480464 | [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of HSPA5 mRNA more ... | CTD | PMID:32152650 |
HSPA5 | Human | glycodeoxycholic acid | multiple interactions | EXP | | 6480464 | [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of HSPA5 mRNA more ... | CTD | PMID:32152650 |
HSPA5 | Human | glycyrrhetinate | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 18alpha-glycyrrhetinic acid inhibits the reaction [bisphenol A results in increased expression of HSPA5 mRNA] | CTD | PMID:35699857 |
HSPA5 | Human | glycyrrhetinic acid | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 18alpha-glycyrrhetinic acid inhibits the reaction [bisphenol A results in increased expression of HSPA5 mRNA] | CTD | PMID:35699857 |
HSPA5 | Human | glyphosate | increases methylation | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Glyphosate results in increased methylation of HSPA5 gene | CTD | PMID:31011160 |
HSPA5 | Human | graphene oxide | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | graphene oxide analog results in decreased expression of HSPA5 mRNA | CTD | PMID:33227293 |
HSPA5 | Human | graphite | increases expression | EXP | | 6480464 | Graphite results in increased expression of HSPA5 protein | CTD | PMID:22157353 |
HSPA5 | Human | Guanabenz | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Guanabenz inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein] | CTD | PMID:24892553 |
HSPA5 | Human | Guanabenz | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Guanabenz inhibits the reaction [Acetaminophen results in increased expression of HSPA5 protein] | CTD | PMID:31524377 |
HSPA5 | Human | GW 4064 | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | GW 4064 inhibits the reaction [[caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of HSPA5 mRNA] | CTD | PMID:28223344 |
HSPA5 | Human | hesperetin | increases expression | EXP | | 6480464 | hesperetin results in increased expression of HSPA5 protein | CTD | PMID:37487865 |
HSPA5 | Human | hesperetin | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [hesperetin results in increased expression of HSPA5 protein] | CTD | PMID:37487865 |
HSPA5 | Human | hesperidin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Hesperidin inhibits the reaction [abamectin results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:34748272 more ... |
HSPA5 | Human | hexadecanoic acid | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Palmitic Acid results in increased expression of HSPA5 mRNA | CTD | PMID:24349266 and PMID:34979142 |
HSPA5 | Human | hexadecanoic acid | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [7-hydroxycoumarin co-treated with Palmitic Acid] results in increased expression of HSPA5 mRNA and [Scopoletin co-treated with Palmitic Acid] results in increased expression of HSPA5 mRNA | CTD | PMID:34979142 |
HSPA5 | Human | hexadecanoic acid | multiple interactions | EXP | | 6480464 | [Palmitic Acid co-treated with Oleic Acid] affects the expression of HSPA5 mRNA | CTD | PMID:30547786 |
HSPA5 | Human | hexadecanoic acid | increases expression | EXP | | 6480464 | Palmitic Acid results in increased expression of HSPA5 protein | CTD | PMID:30738135 |
HSPA5 | Human | hexadecanoic acid | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Palmitic Acid results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:26655953 more ... |
HSPA5 | Human | hexadecanoic acid | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Palmitic Acid results in increased expression of HSPA5 mRNA and Palmitic Acid results in increased expression of HSPA5 protein | CTD | PMID:26655953 more ... |
HSPA5 | Human | homocysteine | multiple interactions | EXP | | 6480464 | Glycine inhibits the reaction [Homocysteine results in increased expression of HSPA5 mRNA] | CTD | PMID:27064126 |
HSPA5 | Human | homocysteine | increases expression | EXP | | 6480464 | Homocysteine results in increased expression of HSPA5 mRNA and Homocysteine results in increased expression of HSPA5 protein | CTD | PMID:19960509 and PMID:27064126 |
HSPA5 | Human | Honokiol | increases expression | EXP | | 6480464 | honokiol results in increased expression of HSPA5 mRNA and honokiol results in increased expression of HSPA5 protein | CTD | PMID:33550458 |
HSPA5 | Human | Honokiol | multiple interactions | EXP | | 6480464 | pyrazolanthrone inhibits the reaction [honokiol results in increased expression of HSPA5 protein] more ... | CTD | PMID:33550458 |
HSPA5 | Human | hyaluronic acid | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Hyaluronic Acid analog affects the expression of HSPA5 protein | CTD | PMID:23178681 |
HSPA5 | Human | hyaluronic acid | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of HSPA5 protein] | CTD | PMID:23178681 |
HSPA5 | Human | hydralazine | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Hydralazine inhibits the reaction [Ethanol results in increased expression of HSPA5 mRNA] | CTD | PMID:28119953 |
HSPA5 | Human | hydrazine | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | hydrazine results in increased expression of HSPA5 mRNA and hydrazine results in increased expression of HSPA5 protein | CTD | PMID:15370871 |
HSPA5 | Human | hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of HSPA5 protein | CTD | PMID:22269385 and PMID:23885834 |
HSPA5 | Human | hydrogen peroxide | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Hydrogen Peroxide results in increased expression of HSPA5 protein | CTD | PMID:22934841 |
HSPA5 | Human | hydrogen peroxide | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Hydrogen Peroxide results in decreased expression of HSPA5 protein | CTD | PMID:23178681 |
HSPA5 | Human | hydrogen peroxide | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of HSPA5 protein] | CTD | PMID:23178681 |
HSPA5 | Human | hydroquinone | increases expression | EXP | | 6480464 | hydroquinone results in increased expression of HSPA5 protein | CTD | PMID:24053669 more ... |
HSPA5 | Human | hydroquinone | multiple interactions | EXP | | 6480464 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of HSPA5 protein] more ... | CTD | PMID:36646296 and PMID:37148176 |
HSPA5 | Human | hydroxytyrosol | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 3 more ... | CTD | PMID:29414845 |
HSPA5 | Human | ibuprofen | decreases expression | EXP | | 6480464 | Ibuprofen results in decreased expression of HSPA5 mRNA | CTD | PMID:25596134 |
HSPA5 | Human | ibuprofen | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Ibuprofen results in decreased expression of HSPA5 mRNA | CTD | PMID:25596134 |
HSPA5 | Human | Ibutilide | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | ibutilide inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA] | CTD | PMID:28399139 |
HSPA5 | Human | icosanoid | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Eicosanoids analog inhibits the reaction [Cisplatin results in increased expression of HSPA5 mRNA] and Eicosanoids analog inhibits the reaction [Cisplatin results in increased expression of HSPA5 protein] | CTD | PMID:23603837 |
HSPA5 | Human | imidacloprid | decreases expression | EXP | | 6480464 | imidacloprid results in decreased expression of HSPA5 protein | CTD | PMID:16884889 |
HSPA5 | Human | indinavir | increases expression | EXP | | 6480464 | Indinavir results in increased expression of HSPA5 mRNA | CTD | PMID:32535746 |
HSPA5 | Human | indometacin | multiple interactions | EXP | | 6480464 | pyrazolanthrone inhibits the reaction [Indomethacin results in increased expression of HSPA5 protein] more ... | CTD | PMID:17341418 |
HSPA5 | Human | indometacin | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Indomethacin results in increased expression of HSPA5 mRNA | CTD | PMID:18799549 |
HSPA5 | Human | indometacin | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Indomethacin results in increased expression of HSPA5 mRNA | CTD | PMID:18799549 |
HSPA5 | Human | indometacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of HSPA5 mRNA and Indomethacin results in increased expression of HSPA5 protein | CTD | PMID:17341418 and PMID:32535746 |
HSPA5 | Human | indoxyl sulfate | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Indican results in increased expression of HSPA5 mRNA | CTD | PMID:29380555 |
HSPA5 | Human | inulin | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of HSPA5 mRNA | CTD | PMID:36331819 |
HSPA5 | Human | iodide salt | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Iodides deficiency results in decreased expression of HSPA5 protein | CTD | PMID:26795019 |
HSPA5 | Human | ionomycin | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HSPA5 mRNA more ... | CTD | PMID:10652249 |
HSPA5 | Human | iprodione | increases expression | EXP | | 6480464 | iprodione results in increased expression of HSPA5 mRNA | CTD | PMID:16696176 |
HSPA5 | Human | iron dichloride | increases expression | EXP | | 6480464 | ferrous chloride results in increased expression of HSPA5 mRNA | CTD | PMID:35984750 |
HSPA5 | Human | isoflavones | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [9 more ... | CTD | PMID:22248470 |
HSPA5 | Human | isoliquiritigenin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Cisplatin co-treated with isoliquiritigenin] results in increased expression of HSPA5 mRNA | CTD | PMID:37561086 |
HSPA5 | Human | isoliquiritigenin | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | isoliquiritigenin results in increased expression of HSPA5 mRNA | CTD | PMID:37561086 |
HSPA5 | Human | isoprenaline | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Isoproterenol results in increased expression of HSPA5 mRNA | CTD | PMID:21335049 |
HSPA5 | Human | isoprenaline | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Acrolein results in increased susceptibility to Isoproterenol] which results in increased expression of HSPA5 protein more ... | CTD | PMID:29414845 |
HSPA5 | Human | isoprenaline | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Isoproterenol results in increased expression of HSPA5 mRNA | CTD | PMID:29414845 |
HSPA5 | Human | isoprenaline | decreases expression | EXP | | 6480464 | Isoproterenol results in decreased expression of HSPA5 mRNA | CTD | PMID:24286936 |
HSPA5 | Human | ivermectin | increases expression | EXP | | 6480464 | Ivermectin results in increased expression of HSPA5 protein | CTD | PMID:30738135 |
HSPA5 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of HSPA5 protein | CTD | PMID:32959892 |
HSPA5 | Human | ketamine | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Ketamine results in decreased expression of HSPA5 mRNA | CTD | PMID:20080153 |
HSPA5 | Human | ketamine | multiple interactions | EXP | | 6480464 | LEP protein promotes the reaction [lipoxin A4 methyl ester inhibits the reaction [Ketamine results in increased expression of HSPA5 protein]] and lipoxin A4 methyl ester inhibits the reaction [Ketamine results in increased expression of HSPA5 protein] | CTD | PMID:36907275 |
HSPA5 | Human | ketamine | affects expression | ISO | Hspa5 (Mus musculus) | 6480464 | Ketamine affects the expression of HSPA5 mRNA | CTD | PMID:35728656 |
HSPA5 | Human | ketamine | increases expression | EXP | | 6480464 | Ketamine results in increased expression of HSPA5 protein | CTD | PMID:36907275 |
HSPA5 | Human | KN-93 | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | KN 93 inhibits the reaction [cadmium acetate results in increased expression of HSPA5 protein] | CTD | PMID:29883672 |
HSPA5 | Human | kojic acid | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPA5 mRNA | CTD | PMID:18544905 |
HSPA5 | Human | L-1,4-dithiothreitol | increases expression | EXP | | 6480464 | Dithiothreitol metabolite results in increased expression of HSPA5 protein more ... | CTD | PMID:15710169 more ... |
HSPA5 | Human | L-1,4-dithiothreitol | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Dithiothreitol metabolite results in increased expression of HSPA5 protein and Dithiothreitol results in increased expression of HSPA5 mRNA | CTD | PMID:17416481 and PMID:23123503 |
HSPA5 | Human | L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [Fenretinide results in increased expression of HSPA5 protein] | CTD | PMID:17353921 |
HSPA5 | Human | L-ascorbic acid | decreases expression | EXP | | 6480464 | Ascorbic Acid results in decreased expression of HSPA5 mRNA | CTD | PMID:19197388 |
HSPA5 | Human | L-glutamine | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Glutamine deficiency results in increased expression of HSPA5 mRNA | CTD | PMID:23123503 |
HSPA5 | Human | L-methionine | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HSPA5 gene more ... | CTD | PMID:20938992 and PMID:23038002 |
HSPA5 | Human | lactacystin | multiple interactions | EXP | | 6480464 | HSPA5 promotes the reaction [lactacystin results in increased expression of APOB protein] more ... | CTD | PMID:15618547 |
HSPA5 | Human | lanthanum atom | multiple interactions | EXP | | 6480464 | Lanthanum binds to and results in increased expression of HSPA5 protein | CTD | PMID:18773883 |
HSPA5 | Human | lead diacetate | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [lead acetate results in increased abundance of Lead] which results in decreased expression of HSPA5 mRNA more ... | CTD | PMID:10702365 more ... |
HSPA5 | Human | lead diacetate | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | lead acetate results in increased expression of HSPA5 mRNA and lead acetate results in increased expression of HSPA5 protein | CTD | PMID:10702365 more ... |
HSPA5 | Human | lead diacetate | affects localization | ISO | Hspa5 (Rattus norvegicus) | 6480464 | lead acetate affects the localization of HSPA5 protein | CTD | PMID:21815057 |
HSPA5 | Human | lead diacetate | affects binding | ISO | Hspa5 (Rattus norvegicus) | 6480464 | lead acetate binds to HSPA5 protein | CTD | PMID:10702365 |
HSPA5 | Human | lead diacetate | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | lead acetate affects the expression of HSPA5 mRNA | CTD | PMID:15111246 |
HSPA5 | Human | lead nitrate | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | lead nitrate results in increased expression of HSPA5 protein | CTD | PMID:20435106 |
HSPA5 | Human | lead nitrate | increases expression | EXP | | 6480464 | lead nitrate results in increased expression of HSPA5 mRNA | CTD | PMID:14971657 |
HSPA5 | Human | lead(0) | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Lead affects the expression of HSPA5 mRNA | CTD | PMID:15111246 |
HSPA5 | Human | lead(0) | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Lead results in increased expression of HSPA5 protein | CTD | PMID:19161237 more ... |
HSPA5 | Human | lead(0) | affects localization | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Lead affects the localization of HSPA5 protein | CTD | PMID:24431214 |
HSPA5 | Human | lead(0) | increases expression | EXP | | 6480464 | Lead results in increased expression of HSPA5 mRNA | CTD | PMID:11032763 |
HSPA5 | Human | lead(0) | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [lead acetate results in increased abundance of Lead] which results in decreased expression of HSPA5 mRNA more ... | CTD | PMID:15111246 more ... |
HSPA5 | Human | lead(II) chloride | decreases expression | EXP | | 6480464 | lead chloride results in decreased expression of HSPA5 protein | CTD | PMID:24419708 |
HSPA5 | Human | lead(II) chloride | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | lead chloride results in increased expression of HSPA5 protein | CTD | PMID:19720107 and PMID:21073006 |
HSPA5 | Human | lead(II) chloride | affects localization | ISO | Hspa5 (Rattus norvegicus) | 6480464 | lead chloride affects the localization of HSPA5 protein | CTD | PMID:19720107 |
HSPA5 | Human | Licochalcone A | multiple interactions | EXP | | 6480464 | HSPA5 protein affects the reaction [licochalcone A results in increased cleavage of CASP3 protein] more ... | CTD | PMID:38308464 |
HSPA5 | Human | Licochalcone A | increases expression | EXP | | 6480464 | licochalcone A results in increased expression of HSPA5 protein | CTD | PMID:38308464 |
HSPA5 | Human | licoricidin | increases expression | EXP | | 6480464 | licoricidin results in increased expression of HSPA5 mRNA and licoricidin results in increased expression of HSPA5 protein | CTD | PMID:37013980 |
HSPA5 | Human | linagliptin | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Linagliptin inhibits the reaction [Cisplatin results in increased expression of HSPA5 mRNA] | CTD | PMID:32567747 |
HSPA5 | Human | linoleic acid | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Linoleic Acid analog results in increased expression of HSPA5 protein | CTD | PMID:27939595 |
HSPA5 | Human | lipoic acid | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of HSPA5 protein] | CTD | PMID:23892647 |
HSPA5 | Human | lipoic acid | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Thioctic Acid inhibits the reaction [cadmium acetate results in increased expression of HSPA5 protein] | CTD | PMID:30605698 |
HSPA5 | Human | lipopolysaccharide | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Lipopolysaccharides results in increased expression of HSPA5 mRNA and Lipopolysaccharides results in increased expression of HSPA5 protein | CTD | PMID:33677747 and PMID:37654027 |
HSPA5 | Human | lipopolysaccharide | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Lipopolysaccharides results in increased expression of HSPA5 protein | CTD | PMID:28245985 |
HSPA5 | Human | lipopolysaccharide | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:28844859 more ... |
HSPA5 | Human | lipopolysaccharide | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of HSPA5 protein] and Vaticanol B inhibits the reaction [Lipopolysaccharides affects the localization of HSPA5 protein] | CTD | PMID:17475668 and PMID:28245985 |
HSPA5 | Human | lipopolysaccharide | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Lipopolysaccharides results in decreased expression of HSPA5 protein | CTD | PMID:21355878 |
HSPA5 | Human | lipopolysaccharide | affects localization | ISO | Hspa5 (Mus musculus) | 6480464 | Lipopolysaccharides affects the localization of HSPA5 protein | CTD | PMID:17475668 |
HSPA5 | Human | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of HSPA5 protein | CTD | PMID:19675143 more ... |
HSPA5 | Human | lipopolysaccharide | multiple interactions | EXP | | 6480464 | 3-methyladenine promotes the reaction [Lipopolysaccharides results in increased expression of HSPA5 protein] more ... | CTD | PMID:22777745 more ... |
HSPA5 | Human | lithium atom | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Pilocarpine co-treated with Lithium] results in increased expression of HSPA5 mRNA more ... | CTD | PMID:21429313 |
HSPA5 | Human | lithium atom | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Lithium results in increased expression of HSPA5 mRNA and Lithium results in increased expression of HSPA5 protein | CTD | PMID:16236328 and PMID:18296634 |
HSPA5 | Human | lithium hydride | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Pilocarpine co-treated with Lithium] results in increased expression of HSPA5 mRNA more ... | CTD | PMID:21429313 |
HSPA5 | Human | lithium hydride | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Lithium results in increased expression of HSPA5 mRNA and Lithium results in increased expression of HSPA5 protein | CTD | PMID:16236328 and PMID:18296634 |
HSPA5 | Human | losartan | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Losartan inhibits the reaction [AGT protein results in increased expression of HSPA5 protein] | CTD | PMID:25398788 |
HSPA5 | Human | luteolin | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Luteolin inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA] and Luteolin inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein] | CTD | PMID:32407927 |
HSPA5 | Human | luteolin | multiple interactions | EXP | | 6480464 | Luteolin inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA] | CTD | PMID:32407927 |
HSPA5 | Human | LY294002 | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with HRAS protein] results in decreased expression of HSPA5 protein | CTD | PMID:24898257 |
HSPA5 | Human | LY294002 | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 protein]] | CTD | PMID:31433112 |
HSPA5 | Human | LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Thapsigargin results in increased expression of HSPA5 mRNA] | CTD | PMID:19428936 |
HSPA5 | Human | lycopene | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Lycopene inhibits the reaction [Oxaliplatin results in increased expression of HSPA5 mRNA] | CTD | PMID:32544411 |
HSPA5 | Human | maneb | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Paraquat co-treated with Maneb] results in increased expression of HSPA5 mRNA | CTD | PMID:18386188 |
HSPA5 | Human | manganese atom | increases expression | EXP | | 6480464 | Manganese results in increased expression of HSPA5 protein | CTD | PMID:21477646 |
HSPA5 | Human | manganese atom | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [manganese chloride results in increased abundance of Manganese] which results in increased expression of HSPA5 mRNA | CTD | PMID:32574669 |
HSPA5 | Human | manganese(0) | increases expression | EXP | | 6480464 | Manganese results in increased expression of HSPA5 protein | CTD | PMID:21477646 |
HSPA5 | Human | manganese(0) | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [manganese chloride results in increased abundance of Manganese] which results in increased expression of HSPA5 mRNA | CTD | PMID:32574669 |
HSPA5 | Human | manganese(II) chloride | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [manganese chloride results in increased abundance of Manganese] which results in increased expression of HSPA5 mRNA more ... | CTD | PMID:23934647 and PMID:32574669 |
HSPA5 | Human | manganese(II) chloride | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | manganese chloride results in increased expression of HSPA5 mRNA and manganese chloride results in increased expression of HSPA5 protein | CTD | PMID:23934647 more ... |
HSPA5 | Human | meglumine amidotrizoate | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Diatrizoate Meglumine results in increased expression of HSPA5 protein | CTD | PMID:20071420 |
HSPA5 | Human | melatonin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Melatonin inhibits the reaction [Aluminum Chloride results in increased expression of HSPA5 protein] more ... | CTD | PMID:20136702 more ... |
HSPA5 | Human | melatonin | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Melatonin inhibits the reaction [bisphenol A results in increased expression of HSPA5 protein] | CTD | PMID:38538260 |
HSPA5 | Human | menadione | multiple interactions | EXP | | 6480464 | Metyrapone promotes the reaction [Vitamin K 3 results in increased expression of HSPA5 protein] and S 3483 promotes the reaction [Vitamin K 3 results in increased expression of HSPA5 protein] | CTD | PMID:19819344 |
HSPA5 | Human | menadione | increases expression | EXP | | 6480464 | Vitamin K 3 results in increased expression of HSPA5 protein | CTD | PMID:19819344 |
HSPA5 | Human | menaquinone | decreases expression | EXP | | 6480464 | Vitamin K 2 results in decreased expression of HSPA5 protein | CTD | PMID:29432837 |
HSPA5 | Human | mercury atom | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Mercury promotes the reaction [HSPA5 protein binds to FOS enhancer] more ... | CTD | PMID:15111246 |
HSPA5 | Human | mercury atom | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Mercury affects the expression of HSPA5 mRNA | CTD | PMID:15111246 |
HSPA5 | Human | mercury dichloride | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Cycloheximide inhibits the reaction [Mercuric Chloride results in increased expression of HSPA5 protein] more ... | CTD | PMID:15111246 and PMID:17915553 |
HSPA5 | Human | mercury dichloride | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Mercuric Chloride results in increased expression of HSPA5 protein | CTD | PMID:32879258 |
HSPA5 | Human | mercury dichloride | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Mercuric Chloride results in increased expression of HSPA5 protein] | CTD | PMID:32879258 |
HSPA5 | Human | mercury dichloride | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Mercuric Chloride results in increased expression of HSPA5 mRNA and Mercuric Chloride results in increased expression of HSPA5 protein | CTD | PMID:17915553 and PMID:30807803 |
HSPA5 | Human | mercury dichloride | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Mercuric Chloride affects the expression of HSPA5 mRNA | CTD | PMID:15111246 |
HSPA5 | Human | mercury(0) | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Mercury promotes the reaction [HSPA5 protein binds to FOS enhancer] more ... | CTD | PMID:15111246 |
HSPA5 | Human | mercury(0) | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Mercury affects the expression of HSPA5 mRNA | CTD | PMID:15111246 |
HSPA5 | Human | metformin | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Metformin results in increased expression of HSPA5 mRNA | CTD | PMID:25596134 |
HSPA5 | Human | metformin | multiple interactions | EXP | | 6480464 | Metformin inhibits the reaction [INS protein results in increased expression of HSPA5 protein] | CTD | PMID:36764371 |
HSPA5 | Human | metformin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Metformin inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of HSPA5 protein] and Metformin inhibits the reaction [Glucose results in increased expression of HSPA5 protein] | CTD | PMID:34801538 |
HSPA5 | Human | metformin | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Metformin inhibits the reaction [Rotenone results in increased expression of HSPA5 mRNA] | CTD | PMID:32189544 |
HSPA5 | Human | methamphetamine | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Methamphetamine results in increased expression of HSPA5 mRNA and Methamphetamine results in increased expression of HSPA5 protein | CTD | PMID:27323860 more ... |
HSPA5 | Human | methamphetamine | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Methamphetamine co-treated with SCH 23390] results in increased expression of HSPA5 mRNA more ... | CTD | PMID:19564919 and PMID:28070110 |
HSPA5 | Human | methamphetamine | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Methamphetamine results in increased expression of HSPA5 mRNA and Methamphetamine results in increased expression of HSPA5 protein | CTD | PMID:19564919 and PMID:28070110 |
HSPA5 | Human | methamphetamine | multiple interactions | EXP | | 6480464 | 1-(6-((3-methoxyestra-1 more ... | CTD | PMID:27323860 more ... |
HSPA5 | Human | methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of HSPA5 mRNA and Methamphetamine results in increased expression of HSPA5 protein | CTD | PMID:27323860 and PMID:33421459 |
HSPA5 | Human | methamphetamine | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Methamphetamine affects the expression of HSPA5 protein | CTD | PMID:19826936 |
HSPA5 | Human | methapyrilene | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Methapyrilene results in increased expression of HSPA5 mRNA | CTD | PMID:15120968 and PMID:17450226 |
HSPA5 | Human | methomyl | increases expression | EXP | | 6480464 | Methomyl results in increased expression of HSPA5 protein | CTD | PMID:16271832 |
HSPA5 | Human | methotrexate | multiple interactions | EXP | | 6480464 | [Methotrexate co-treated with theaflavin-3 and 3'-digallate] results in decreased expression of HSPA5 protein | CTD | PMID:34350509 |
HSPA5 | Human | methotrexate | decreases expression | EXP | | 6480464 | Methotrexate results in decreased expression of HSPA5 protein | CTD | PMID:34350509 |
HSPA5 | Human | methyl beta-cyclodextrin | multiple interactions | EXP | | 6480464 | methyl-beta-cyclodextrin inhibits the reaction [(1-pentyl-1H-indol-3-yl)(2 more ... | CTD | PMID:30502353 |
HSPA5 | Human | methylmercury chloride | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | methylmercuric chloride results in increased expression of HSPA5 mRNA and methylmercuric chloride results in increased expression of HSPA5 protein | CTD | PMID:31330229 |
HSPA5 | Human | methylmercury chloride | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of HSPA5 protein] more ... | CTD | PMID:31330229 |
HSPA5 | Human | methylparaben | increases expression | EXP | | 6480464 | methylparaben results in increased expression of HSPA5 mRNA | CTD | PMID:31745603 |
HSPA5 | Human | methylseleninic acid | multiple interactions | EXP | | 6480464 | HSPA5 protein affects the reaction [methylselenic acid results in decreased expression of CDK1 protein] more ... | CTD | PMID:16204082 and PMID:16205645 |
HSPA5 | Human | methylseleninic acid | increases expression | EXP | | 6480464 | methylselenic acid results in increased expression of HSPA5 mRNA and methylselenic acid results in increased expression of HSPA5 protein | CTD | PMID:16204082 more ... |
HSPA5 | Human | metyrapone | multiple interactions | EXP | | 6480464 | Metyrapone promotes the reaction [Vitamin K 3 results in increased expression of HSPA5 protein] | CTD | PMID:19819344 |
HSPA5 | Human | microcystin RR | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | microcystin RR results in increased expression of HSPA5 protein | CTD | PMID:20196164 |
HSPA5 | Human | microcystin-LR | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | cyanoginosin LR results in increased expression of HSPA5 protein | CTD | PMID:33290805 |
HSPA5 | Human | microcystin-LR | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | cyanoginosin LR results in increased expression of HSPA5 protein | CTD | PMID:22430071 |
HSPA5 | Human | minocycline | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Minocycline inhibits the reaction [Paraquat results in increased expression of HSPA5 protein] | CTD | PMID:22245251 |
HSPA5 | Human | mithramycin | multiple interactions | EXP | | 6480464 | Plicamycin inhibits the reaction [Butyric Acid results in increased expression of HSPA5 protein] | CTD | PMID:26784903 |
HSPA5 | Human | MitoTEMPO | multiple interactions | EXP | | 6480464 | MitoTEMPO inhibits the reaction [Benomyl results in increased expression of HSPA5 protein] | CTD | PMID:27784618 |
HSPA5 | Human | mono(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate inhibits the reaction [4-phenylbutyric acid results in decreased expression of HSPA5 protein] | CTD | PMID:36005737 |
HSPA5 | Human | mono(2-ethylhexyl) phthalate | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of GRP78 protein | CTD | PMID:37979351 |
HSPA5 | Human | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2 more ... | CTD | PMID:37979351 |
HSPA5 | Human | mono(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of HSPA5 protein | CTD | PMID:36005737 |
HSPA5 | Human | Monobutylphthalate | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | monobutyl phthalate results in increased expression of HSPA5 protein | CTD | PMID:20553848 |
HSPA5 | Human | monosodium L-glutamate | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Sodium Glutamate results in increased expression of HSPA5 mRNA | CTD | PMID:28954212 |
HSPA5 | Human | morphine | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Morphine results in increased expression of HSPA5 protein | CTD | PMID:37394652 |
HSPA5 | Human | morphine | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | corilagin inhibits the reaction [Morphine results in increased expression of HSPA5 protein] and TLR2 protein inhibits the reaction [corilagin inhibits the reaction [Morphine results in increased expression of HSPA5 protein]] | CTD | PMID:37394652 |
HSPA5 | Human | morusin | increases expression | EXP | | 6480464 | morusin results in increased expression of HSPA5 protein | CTD | PMID:29421517 |
HSPA5 | Human | morusin | multiple interactions | EXP | | 6480464 | 4 more ... | CTD | PMID:29421517 |
HSPA5 | Human | mycophenolic acid | decreases expression | EXP | | 6480464 | Mycophenolic Acid results in decreased expression of HSPA5 mRNA | CTD | PMID:24356939 |
HSPA5 | Human | myriocin | multiple interactions | EXP | | 6480464 | thermozymocidin inhibits the reaction [fumonisin B1 results in increased expression of HSPA5 protein] | CTD | PMID:31891755 |
HSPA5 | Human | N(gamma)-nitro-L-arginine methyl ester | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Huang Qi co-treated with Coptidis rhizoma extract co-treated with Aconitic Acid co-treated with Centella asiatica extract] inhibits the reaction [[Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of HSPA5 mRNA] and [Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of HSPA5 mRNA | CTD | PMID:38282657 |
HSPA5 | Human | N,N-dimethylformamide | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of HSPA5 mRNA and [Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of HSPA5 protein | CTD | PMID:20097184 |
HSPA5 | Human | N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris(1 more ... | CTD | PMID:24802810 more ... |
HSPA5 | Human | N-acetyl-L-cysteine | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Acetylcysteine results in decreased expression of HSPA5 protein | CTD | PMID:27484784 |
HSPA5 | Human | N-acetyl-L-cysteine | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:21145380 more ... |
HSPA5 | Human | N-acetyl-L-cysteine | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:20493918 more ... |
HSPA5 | Human | N-acetyl-L-cysteine | increases expression | EXP | | 6480464 | Acetylcysteine results in increased expression of HSPA5 protein | CTD | PMID:19722195 |
HSPA5 | Human | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases expression | EXP | | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of HSPA5 protein | CTD | PMID:19139269 and PMID:21692457 |
HSPA5 | Human | N-hexadecanoylsphingosine | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of HSPA5 mRNA more ... | CTD | PMID:28223344 |
HSPA5 | Human | N-hexadecanoylsphingosine | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | N-palmitoylsphingosine results in increased expression of HSPA5 mRNA | CTD | PMID:28223344 |
HSPA5 | Human | N-methyl-4-phenylpyridinium | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of HSPA5 mRNA and 1-Methyl-4-phenylpyridinium results in increased expression of HSPA5 protein | CTD | PMID:16026605 more ... |
HSPA5 | Human | N-methyl-4-phenylpyridinium | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Nicotine inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HSPA5 protein] and TXN protein affects the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HSPA5 protein] | CTD | PMID:24140863 and PMID:28082123 |
HSPA5 | Human | N-methyl-4-phenylpyridinium | multiple interactions | EXP | | 6480464 | chikusetsusaponin V inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HSPA5 protein] and TXN protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HSPA5 protein] | CTD | PMID:24140863 and PMID:25073091 |
HSPA5 | Human | N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of HSPA5 protein | CTD | PMID:24675778 and PMID:25073091 |
HSPA5 | Human | N-methylnicotinate | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | trigonelline inhibits the reaction [Palmitic Acid results in increased expression of HSPA5 protein] | CTD | PMID:30208301 |
HSPA5 | Human | N-nitrosodiethylamine | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPA5 mRNA | CTD | PMID:18544905 |
HSPA5 | Human | N-nitrosodiethylamine | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Diethylnitrosamine results in decreased expression of HSPA5 mRNA | CTD | PMID:11323195 |
HSPA5 | Human | N-nitrosomorpholine | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | N-nitrosomorpholine results in decreased expression of HSPA5 protein | CTD | PMID:19716841 |
HSPA5 | Human | naloxone | increases expression | EXP | | 6480464 | Naloxone results in increased expression of HSPA5 protein | CTD | PMID:26377394 |
HSPA5 | Human | naltrexone | multiple interactions | EXP | | 6480464 | Naltrexone inhibits the reaction [Methamphetamine results in increased expression of HSPA5 mRNA] | CTD | PMID:27323860 |
HSPA5 | Human | naphthalene | affects binding | ISO | Hspa5 (Mus musculus) | 6480464 | naphthalene metabolite binds to HSPA5 protein | CTD | PMID:16206326 |
HSPA5 | Human | naphthalene | increases reduction | ISO | Hspa5 (Mus musculus) | 6480464 | naphthalene results in increased reduction of HSPA5 protein | CTD | PMID:19843705 |
HSPA5 | Human | naringin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | naringin inhibits the reaction [Oxaliplatin results in increased expression of HSPA5 mRNA] | CTD | PMID:38037725 |
HSPA5 | Human | nefazodone | multiple interactions | EXP | | 6480464 | [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of HSPA5 mRNA | CTD | PMID:32152650 |
HSPA5 | Human | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of HSPA5 mRNA | CTD | PMID:32152650 |
HSPA5 | Human | nelfinavir | increases expression | EXP | | 6480464 | Nelfinavir results in increased expression of HSPA5 and Nelfinavir results in increased expression of HSPA5 protein | CTD | PMID:19106637 more ... |
HSPA5 | Human | nelfinavir | multiple interactions | EXP | | 6480464 | Tamoxifen promotes the reaction [Nelfinavir results in increased expression of HSPA5 protein] | CTD | PMID:20594311 |
HSPA5 | Human | nickel atom | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Nickel inhibits the reaction [lead acetate binds to HSPA5 protein] | CTD | PMID:10702365 |
HSPA5 | Human | nickel sulfate | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:28296042 |
HSPA5 | Human | nickel sulfate | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | nickel sulfate results in increased expression of HSPA5 mRNA and nickel sulfate results in increased expression of HSPA5 protein | CTD | PMID:28296042 |
HSPA5 | Human | nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of HSPA5 | CTD | PMID:24201001 |
HSPA5 | Human | nicotine | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Nicotine inhibits the reaction [1-Methyl-4-phenyl-1 more ... | CTD | PMID:28082123 |
HSPA5 | Human | nicotine | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Nicotine inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HSPA5 protein] and Nicotine inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein] | CTD | PMID:18477628 and PMID:28082123 |
HSPA5 | Human | nifedipine | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Nifedipine inhibits the reaction [Oxygen deficiency results in increased expression of HSPA5 mRNA] and Nifedipine inhibits the reaction [Oxygen deficiency results in increased expression of HSPA5 protein] | CTD | PMID:22226148 |
HSPA5 | Human | nilotinib | increases expression | EXP | | 6480464 | nilotinib results in increased expression of HSPA5 mRNA | CTD | PMID:23883479 |
HSPA5 | Human | nilotinib | multiple interactions | EXP | | 6480464 | Arsenic Trioxide promotes the reaction [nilotinib results in increased expression of HSPA5 mRNA] | CTD | PMID:23883479 |
HSPA5 | Human | nitrates | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of HSPA5 mRNA | CTD | PMID:35964746 |
HSPA5 | Human | nitric oxide | multiple interactions | EXP | | 6480464 | [NOS3 protein polymorphism results in decreased chemical synthesis of Nitric Oxide] which results in decreased expression of HSPA5 mRNA and [NOS3 protein polymorphism results in decreased chemical synthesis of Nitric Oxide] which results in decreased expression of HSPA5 protein | CTD | PMID:19320461 |
HSPA5 | Human | nitric oxide | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Nitroprusside results in increased abundance of Nitric Oxide] which results in decreased expression of HSPA5 protein | CTD | PMID:18675883 |
HSPA5 | Human | nitrogen dioxide | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of [Particulate Matter co-treated with Nitrogen Dioxide]] which results in increased expression of HSPA5 mRNA | CTD | PMID:35091019 |
HSPA5 | Human | nitroprusside | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Nitroprusside results in increased expression of HSPA5 protein | CTD | PMID:18675883 |
HSPA5 | Human | nitroprusside | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Nitroprusside results in increased abundance of Nitric Oxide] which results in decreased expression of HSPA5 protein | CTD | PMID:18675883 |
HSPA5 | Human | Nivalenol | decreases expression | EXP | | 6480464 | nivalenol results in decreased expression of HSPA5 mRNA | CTD | PMID:20682335 |
HSPA5 | Human | NMS-873 | increases expression | EXP | | 6480464 | NMS-873 results in increased expression of HSPA5 protein | CTD | PMID:23892893 and PMID:29693262 |
HSPA5 | Human | nocodazole | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Nocodazole results in increased expression of HSPA5 protein | CTD | PMID:26732598 |
HSPA5 | Human | Nodularin | increases expression | EXP | | 6480464 | nodularin results in increased expression of HSPA5 mRNA | CTD | PMID:27061667 |
HSPA5 | Human | Nonidet P-40 | decreases expression | EXP | | 6480464 | Nonidet P-40 results in decreased expression of HSPA5 mRNA | CTD | PMID:26552463 |
HSPA5 | Human | nonivamide | multiple interactions | EXP | | 6480464 | [nonivamide binds to and results in increased activity of TRPV1 protein] which results in increased expression of HSPA5 mRNA | CTD | PMID:17332266 |
HSPA5 | Human | nonivamide | increases expression | EXP | | 6480464 | nonivamide results in increased expression of HSPA5 mRNA | CTD | PMID:17332266 |
HSPA5 | Human | Nonylphenol | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | nonylphenol affects the expression of HSPA5 protein | CTD | PMID:19429228 |
HSPA5 | Human | Nonylphenol | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | nonylphenol results in increased expression of HSPA5 mRNA | CTD | PMID:19429228 |
HSPA5 | Human | Norbinaltorphimine | multiple interactions | EXP | | 6480464 | norbinaltorphimine inhibits the reaction [Methamphetamine results in increased expression of HSPA5 mRNA] | CTD | PMID:27323860 |
HSPA5 | Human | obeticholic acid | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | obeticholic acid inhibits the reaction [Dietary Fats results in increased expression of HSPA5 protein] and obeticholic acid inhibits the reaction [Palmitic Acid results in increased expression of HSPA5 protein] | CTD | PMID:26655953 |
HSPA5 | Human | ochratoxin A | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | ochratoxin A results in decreased expression of HSPA5 protein | CTD | PMID:19445961 |
HSPA5 | Human | ochratoxin A | decreases methylation | EXP | | 6480464 | ochratoxin A results in decreased methylation of HSPA5 promoter | CTD | PMID:30559759 |
HSPA5 | Human | ochratoxin A | increases expression | EXP | | 6480464 | ochratoxin A metabolite results in increased expression of HSPA5 mRNA more ... | CTD | PMID:24356939 more ... |
HSPA5 | Human | ochratoxin A | multiple interactions | EXP | | 6480464 | ochratoxin A promotes the reaction [bardoxolone methyl results in increased expression of HSPA5 protein] more ... | CTD | PMID:33465424 and PMID:36587836 |
HSPA5 | Human | ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of HSPA5 mRNA | CTD | PMID:19051279 |
HSPA5 | Human | okadaic acid | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Okadaic Acid results in increased expression of HSPA5 protein | CTD | PMID:26732598 |
HSPA5 | Human | oleanolic acid | multiple interactions | EXP | | 6480464 | Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of HSPA5 protein] and TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of HSPA5 protein]] | CTD | PMID:33465424 |
HSPA5 | Human | oleic acid | multiple interactions | EXP | | 6480464 | [Palmitic Acid co-treated with Oleic Acid] affects the expression of HSPA5 mRNA | CTD | PMID:30547786 |
HSPA5 | Human | oleic acid | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Oleic Acid co-treated with Palmitic Acid] results in increased expression of HSPA5 protein more ... | CTD | PMID:32976987 and PMID:37009739 |
HSPA5 | Human | oleic acid | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Oleic Acid results in increased expression of HSPA5 mRNA | CTD | PMID:24349266 |
HSPA5 | Human | oleuropein | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | oleuropein inhibits the reaction [Acrolein results in increased expression of HSPA5 protein] | CTD | PMID:29414845 |
HSPA5 | Human | orlistat | increases expression | EXP | | 6480464 | orlistat results in increased expression of HSPA5 mRNA | CTD | PMID:17283163 |
HSPA5 | Human | ouabain | increases expression | EXP | | 6480464 | Ouabain results in increased expression of HSPA5 protein | CTD | PMID:31436044 |
HSPA5 | Human | oxaliplatin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Lycopene inhibits the reaction [Oxaliplatin results in increased expression of HSPA5 mRNA] and naringin inhibits the reaction [Oxaliplatin results in increased expression of HSPA5 mRNA] | CTD | PMID:32544411 and PMID:38037725 |
HSPA5 | Human | oxaliplatin | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Oxaliplatin results in increased expression of HSPA5 mRNA | CTD | PMID:32544411 and PMID:38037725 |
HSPA5 | Human | oxidopamine | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Oxidopamine results in increased expression of HSPA5 mRNA and Oxidopamine results in increased expression of HSPA5 protein | CTD | PMID:12486162 more ... |
HSPA5 | Human | oxidopamine | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Resveratrol inhibits the reaction [Oxidopamine results in increased expression of HSPA5 protein] and sodium bisulfide inhibits the reaction [Oxidopamine results in increased expression of HSPA5 protein] | CTD | PMID:33961902 and PMID:34302886 |
HSPA5 | Human | oxycodone | increases expression | EXP | | 6480464 | Oxycodone results in increased expression of HSPA5 protein | CTD | PMID:26377394 |
HSPA5 | Human | oxycodone | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Oxycodone results in increased expression of HSPA5 protein | CTD | PMID:26377394 |
HSPA5 | Human | ozone | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of HSPA5 mRNA | CTD | PMID:18636392 |
HSPA5 | Human | ozone | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Ozone results in increased expression of HSPA5 protein | CTD | PMID:29956773 |
HSPA5 | Human | ozone | decreases expression | EXP | | 6480464 | Ozone results in decreased expression of HSPA5 mRNA | CTD | PMID:23033980 |
HSPA5 | Human | ozone | increases phosphorylation | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Ozone results in increased phosphorylation of HSPA5 protein | CTD | PMID:33146391 |
HSPA5 | Human | ozone | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Ozone results in increased expression of HSPA5 mRNA | CTD | PMID:21543283 |
HSPA5 | Human | p-menthan-3-ol | increases expression | EXP | | 6480464 | Menthol results in increased expression of HSPA5 mRNA and Menthol results in increased expression of HSPA5 protein | CTD | PMID:26760959 |
HSPA5 | Human | Pachymic acid | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | pachymic acid inhibits the reaction [Bleomycin results in increased expression of HSPA5 protein] | CTD | PMID:37163307 |
HSPA5 | Human | paclitaxel | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Paclitaxel results in increased expression of HSPA5 mRNA and Paclitaxel results in increased expression of HSPA5 protein | CTD | PMID:26732598 and PMID:36966900 |
HSPA5 | Human | paclitaxel | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Hesperidin inhibits the reaction [Paclitaxel results in increased expression of HSPA5 mRNA] | CTD | PMID:36966900 |
HSPA5 | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of HSPA5 mRNA | CTD | PMID:29067470 |
HSPA5 | Human | paracetamol | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of HSPA5 mRNA | CTD | PMID:33387578 |
HSPA5 | Human | paracetamol | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Acetaminophen results in increased expression of HSPA5 protein] and Guanabenz inhibits the reaction [Acetaminophen results in increased expression of HSPA5 protein] | CTD | PMID:31524377 and PMID:38042273 |
HSPA5 | Human | paracetamol | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Acetaminophen results in increased expression of HSPA5 protein | CTD | PMID:31524377 and PMID:38042273 |
HSPA5 | Human | paracetamol | affects expression | ISO | Hspa5 (Mus musculus) | 6480464 | Acetaminophen affects the expression of HSPA5 mRNA | CTD | PMID:15606129 and PMID:17562736 |
HSPA5 | Human | paraoxon | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Egtazic Acid co-treated with Paraoxon] results in increased expression of HSPA5 protein and [Procaine co-treated with Paraoxon] results in increased expression of HSPA5 protein | CTD | PMID:26998625 |
HSPA5 | Human | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of HSPA5 mRNA and Paraquat results in increased expression of HSPA5 protein | CTD | PMID:19735704 more ... |
HSPA5 | Human | paraquat | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Paraquat results in increased expression of HSPA5 protein | CTD | PMID:27442881 |
HSPA5 | Human | paraquat | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Paraquat results in increased expression of HSPA5 mRNA and Paraquat results in increased expression of HSPA5 protein | CTD | PMID:17935786 more ... |
HSPA5 | Human | paraquat | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Paraquat co-treated with Maneb] results in increased expression of HSPA5 mRNA | CTD | PMID:18386188 |
HSPA5 | Human | paraquat | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Minocycline inhibits the reaction [Paraquat results in increased expression of HSPA5 protein] more ... | CTD | PMID:22245251 and PMID:22678742 |
HSPA5 | Human | paraquat | multiple interactions | EXP | | 6480464 | EIF2S1 protein promotes the reaction [salubrinal inhibits the reaction [Paraquat results in increased expression of HSPA5 protein]] more ... | CTD | PMID:19735704 more ... |
HSPA5 | Human | patulin | increases expression | EXP | | 6480464 | Patulin results in increased expression of HSPA5 protein | CTD | PMID:25577197 |
HSPA5 | Human | perfluorobutyric acid | increases expression | EXP | | 6480464 | perfluorobutyric acid results in increased expression of HSPA5 mRNA | CTD | PMID:36251517 |
HSPA5 | Human | perfluorodecanoic acid | increases metabolic processing | ISO | Hspa5 (Rattus norvegicus) | 6480464 | perfluorodecanoic acid results in increased metabolism of HSPA5 protein | CTD | PMID:7958552 |
HSPA5 | Human | perfluorodecanoic acid | increases phosphorylation | ISO | Hspa5 (Rattus norvegicus) | 6480464 | perfluorodecanoic acid results in increased phosphorylation of HSPA5 protein | CTD | PMID:7880882 |
HSPA5 | Human | perfluorododecanoic acid | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | perfluorododecanoic acid affects the expression of HSPA5 protein | CTD | PMID:26168851 |
HSPA5 | Human | perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of HSPA5 mRNA | CTD | PMID:32790152 |
HSPA5 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of HSPA5 mRNA more ... | CTD | PMID:36331819 |
HSPA5 | Human | perfluorooctane-1-sulfonic acid | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | perfluorooctane sulfonic acid results in increased expression of HSPA5 protein | CTD | PMID:34006824 |
HSPA5 | Human | perfluorooctanoic acid | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | perfluorooctanoic acid results in decreased expression of HSPA5 mRNA | CTD | PMID:21318169 |
HSPA5 | Human | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of HSPA5 mRNA and perfluorooctanoic acid results in increased expression of HSPA5 protein | CTD | PMID:35123991 and PMID:36251517 |
HSPA5 | Human | perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of HSPA5 mRNA | CTD | PMID:32790152 |
HSPA5 | Human | perfluorooctanoic acid | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | perfluorooctanoic acid results in increased expression of HSPA5 mRNA | CTD | PMID:32578922 and PMID:37044272 |
HSPA5 | Human | perfluorooctanoic acid | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | perfluorooctanoic acid results in increased expression of HSPA5 mRNA | CTD | PMID:35163327 |
HSPA5 | Human | perfluorooctanoic acid | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | PPARA protein affects the reaction [perfluorooctanoic acid results in decreased expression of HSPA5 mRNA] | CTD | PMID:21318169 |
HSPA5 | Human | phenethyl caffeate | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of HSPA5 mRNA more ... | CTD | PMID:28223344 |
HSPA5 | Human | phenobarbital | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Phenobarbital inhibits the reaction [Dietary Fats results in increased expression of HSPA5 mRNA] | CTD | PMID:36657701 |
HSPA5 | Human | PhIP | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in increased expression of HSPA5 mRNA | CTD | PMID:15215175 |
HSPA5 | Human | phlorizin | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Phlorhizin results in increased expression of HSPA5 mRNA | CTD | PMID:22538082 |
HSPA5 | Human | phorbol 13-acetate 12-myristate | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HSPA5 mRNA more ... | CTD | PMID:10652249 |
HSPA5 | Human | pirimicarb | increases expression | EXP | | 6480464 | pirimicarb results in increased expression of HSPA5 protein | CTD | PMID:16271832 |
HSPA5 | Human | pirinixic acid | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | PPARA protein affects the reaction [pirinixic acid results in decreased expression of HSPA5 mRNA] | CTD | PMID:21318169 |
HSPA5 | Human | pirinixic acid | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of HSPA5 mRNA | CTD | PMID:21318169 and PMID:23811191 |
HSPA5 | Human | platycodin D | increases expression | EXP | | 6480464 | platycodin D results in increased expression of HSPA5 mRNA | CTD | PMID:22784044 |
HSPA5 | Human | plumbagin | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [plumbagin results in increased expression of HSPA5 protein] and Cycloheximide inhibits the reaction [plumbagin results in increased expression of HSPA5 protein] | CTD | PMID:31276663 |
HSPA5 | Human | plumbagin | increases expression | EXP | | 6480464 | plumbagin results in increased expression of HSPA5 protein | CTD | PMID:31276663 |
HSPA5 | Human | poly(guanylic acid) | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Poly G inhibits the reaction [Silicon Dioxide results in increased expression of HSPA5 protein] | CTD | PMID:31028789 |
HSPA5 | Human | potassium dichromate | increases expression | EXP | | 6480464 | Potassium Dichromate results in increased expression of HSPA5 protein | CTD | PMID:32569804 |
HSPA5 | Human | potassium dichromate | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of HSPA5 protein | CTD | PMID:30974164 |
HSPA5 | Human | potassium dichromate | multiple interactions | EXP | | 6480464 | 3-methyladenine promotes the reaction [Potassium Dichromate results in increased expression of HSPA5 protein] and 4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of HSPA5 protein] | CTD | PMID:32569804 |
HSPA5 | Human | potassium iodide | multiple interactions | EXP | | 6480464 | Potassium Iodide inhibits the reaction [Sodium Fluoride results in increased expression of HSPA5 mRNA] and Potassium Iodide inhibits the reaction [Sodium Fluoride results in increased expression of HSPA5 protein] | CTD | PMID:24231001 |
HSPA5 | Human | proanthocyanidin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Proanthocyanidins inhibits the reaction [lead acetate results in increased expression of HSPA5 protein] | CTD | PMID:25088297 |
HSPA5 | Human | procaine | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Procaine co-treated with Paraoxon] results in increased expression of HSPA5 protein | CTD | PMID:26998625 |
HSPA5 | Human | procymidone | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | procymidone results in decreased expression of HSPA5 mRNA | CTD | PMID:15686871 |
HSPA5 | Human | procymidone | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | procymidone results in increased expression of HSPA5 mRNA and procymidone results in increased expression of HSPA5 protein | CTD | PMID:35913088 |
HSPA5 | Human | progesterone | affects expression | ISO | Hspa5 (Mus musculus) | 6480464 | Progesterone affects the expression of HSPA5 mRNA | CTD | PMID:17251523 |
HSPA5 | Human | propiconazole | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | propiconazole results in increased expression of HSPA5 mRNA | CTD | PMID:21278054 |
HSPA5 | Human | propylparaben | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | propylparaben results in increased expression of HSPA5 mRNA | CTD | PMID:36277366 |
HSPA5 | Human | psoralen | increases expression | EXP | | 6480464 | Ficusin results in increased expression of HSPA5 mRNA and Ficusin results in increased expression of HSPA5 protein | CTD | PMID:31364909 |
HSPA5 | Human | psoralen | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of HSPA5 protein] | CTD | PMID:39299507 |
HSPA5 | Human | psoralen | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Ficusin results in increased expression of HSPA5 protein | CTD | PMID:39299507 |
HSPA5 | Human | psoralen | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of HSPA5 mRNA] and 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of HSPA5 protein] | CTD | PMID:31364909 |
HSPA5 | Human | pterostilbene | increases expression | EXP | | 6480464 | pterostilbene results in increased expression of HSPA5 mRNA and pterostilbene results in increased expression of HSPA5 protein | CTD | PMID:25341683 |
HSPA5 | Human | pterostilbene | multiple interactions | EXP | | 6480464 | 2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased expression of HSPA5 protein] more ... | CTD | PMID:25341683 |
HSPA5 | Human | pyrazinecarboxamide | increases expression | EXP | | 6480464 | Pyrazinamide results in increased expression of HSPA5 mRNA and Pyrazinamide results in increased expression of HSPA5 protein | CTD | PMID:28063906 |
HSPA5 | Human | pyrazinecarboxamide | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased expression of HSPA5 protein] | CTD | PMID:28063906 |
HSPA5 | Human | pyrazinecarboxamide | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Pyrazinamide results in increased expression of HSPA5 protein | CTD | PMID:28063906 |
HSPA5 | Human | pyrazinecarboxamide | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased expression of HSPA5 protein] | CTD | PMID:28063906 |
HSPA5 | Human | pyrrolidine dithiocarbamate | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of HSPA5 mRNA more ... | CTD | PMID:20920558 |
HSPA5 | Human | quercetin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with Quercetin] results in increased expression of HSPA5 mRNA more ... | CTD | PMID:19017364 more ... |
HSPA5 | Human | quercetin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Quercetin inhibits the reaction [Vincristine results in increased expression of HSPA5 mRNA] | CTD | PMID:33038355 |
HSPA5 | Human | quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of HSPA5 mRNA and Quercetin results in increased expression of HSPA5 protein | CTD | PMID:14750173 more ... |
HSPA5 | Human | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of HSPA5 mRNA | CTD | PMID:21632981 |
HSPA5 | Human | quercetin | decreases response to substance | EXP | | 6480464 | HSPA5 protein results in decreased susceptibility to Quercetin | CTD | PMID:19017364 |
HSPA5 | Human | quercetin | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Quercetin affects the expression of HSPA5 mRNA | CTD | PMID:18178720 |
HSPA5 | Human | rac-lactic acid | multiple interactions | EXP | | 6480464 | HSPA5 protein affects the reaction [A2M protein modified form results in increased secretion of Lactic Acid] | CTD | PMID:25720493 |
HSPA5 | Human | Repaglinide | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | repaglinide inhibits the reaction [Rotenone results in increased expression of HSPA5 protein] | CTD | PMID:36538285 |
HSPA5 | Human | resveratrol | decreases expression | EXP | | 6480464 | Resveratrol results in decreased expression of HSPA5 mRNA and Resveratrol results in decreased expression of HSPA5 protein | CTD | PMID:20717957 |
HSPA5 | Human | resveratrol | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | resveratrol results in decreased expression of HSPA5 protein | CTD | PMID:24395567 |
HSPA5 | Human | resveratrol | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Resveratrol results in increased expression of HSPA5 protein | CTD | PMID:25505154 and PMID:37482209 |
HSPA5 | Human | resveratrol | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 protein]] more ... | CTD | PMID:26055348 more ... |
HSPA5 | Human | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of HSPA5 protein | CTD | PMID:17914584 more ... |
HSPA5 | Human | resveratrol | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Resveratrol results in decreased activity of MTOR protein] inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA] and Resveratrol inhibits the reaction [Acrolein results in increased expression of HSPA5 protein] | CTD | PMID:21321189 and PMID:34813903 |
HSPA5 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of HSPA5 mRNA more ... | CTD | PMID:23557933 more ... |
HSPA5 | Human | rifampicin | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Rifampin results in increased expression of HSPA5 protein | CTD | PMID:24638036 |
HSPA5 | Human | rifampicin | increases expression | EXP | | 6480464 | Rifampin results in increased expression of HSPA5 mRNA and Rifampin results in increased expression of HSPA5 protein | CTD | PMID:27470132 and PMID:32535746 |
HSPA5 | Human | rifampicin | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of HSPA5 mRNA] and 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of HSPA5 protein] | CTD | PMID:27470132 |
HSPA5 | Human | rifampicin | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Rifampin co-treated with Cobicistat] results in increased expression of HSPA5 mRNA | CTD | PMID:33629115 |
HSPA5 | Human | rifampicin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | ATF4 mutant form inhibits the reaction [Rifampin results in increased expression of HSPA5 protein] | CTD | PMID:24638036 |
HSPA5 | Human | Riluzole | increases expression | EXP | | 6480464 | Riluzole results in increased expression of HSPA5 protein | CTD | PMID:30280407 |
HSPA5 | Human | rimonabant | multiple interactions | EXP | | 6480464 | [Rimonabant co-treated with SR 144528] inhibits the reaction [Dronabinol results in increased expression of HSPA5 mRNA] | CTD | PMID:31054322 |
HSPA5 | Human | Roridin A | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | roridin A results in increased degradation of and results in decreased expression of HSPA5 protein | CTD | PMID:19336499 |
HSPA5 | Human | rotenone | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Rotenone results in increased expression of HSPA5 protein] more ... | CTD | PMID:17459145 more ... |
HSPA5 | Human | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of HSPA5 mRNA | CTD | PMID:36586010 |
HSPA5 | Human | rotenone | increases oxidation | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Rotenone results in increased oxidation of HSPA5 protein | CTD | PMID:30951809 |
HSPA5 | Human | rotenone | multiple interactions | EXP | | 6480464 | MIR384 mRNA promotes the reaction [Rotenone results in decreased expression of HSPA5 mRNA] | CTD | PMID:26864693 |
HSPA5 | Human | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of HSPA5 mRNA | CTD | PMID:26864693 and PMID:33512557 |
HSPA5 | Human | rotenone | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Rotenone results in increased expression of HSPA5 mRNA and Rotenone results in increased expression of HSPA5 protein | CTD | PMID:26446018 more ... |
HSPA5 | Human | rotenone | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2 more ... | CTD | PMID:26446018 more ... |
HSPA5 | Human | rotenone | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Rotenone results in increased expression of HSPA5 mRNA and Rotenone results in increased expression of HSPA5 protein | CTD | PMID:17459145 more ... |
HSPA5 | Human | rottlerin | increases expression | EXP | | 6480464 | rottlerin results in increased expression of HSPA5 protein | CTD | PMID:22410117 |
HSPA5 | Human | Rutecarpine | increases expression | EXP | | 6480464 | rutecarpine results in increased expression of HSPA5 mRNA | CTD | PMID:34955744 |
HSPA5 | Human | S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | EXP | | 6480464 | Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased expression of HSPA5 protein] | CTD | PMID:25341683 |
HSPA5 | Human | Salidroside | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | rhodioloside inhibits the reaction [furan results in increased expression of HSPA5 mRNA] and rhodioloside inhibits the reaction [furan results in increased expression of HSPA5 protein] | CTD | PMID:34450210 |
HSPA5 | Human | Salinomycin | increases expression | EXP | | 6480464 | salinomycin results in increased expression of HSPA5 mRNA | CTD | PMID:35914560 |
HSPA5 | Human | Salinomycin | multiple interactions | EXP | | 6480464 | [Calcitriol co-treated with salinomycin] results in increased expression of HSPA5 mRNA and Calcitriol promotes the reaction [salinomycin results in increased expression of HSPA5 mRNA] | CTD | PMID:35914560 |
HSPA5 | Human | salubrinal | multiple interactions | EXP | | 6480464 | EIF2S1 protein promotes the reaction [salubrinal inhibits the reaction [Paraquat results in increased expression of HSPA5 protein]] more ... | CTD | PMID:19735704 more ... |
HSPA5 | Human | salubrinal | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | salubrinal inhibits the reaction [Rotenone results in increased expression of HSPA5 protein] more ... | CTD | PMID:25428620 and PMID:34673134 |
HSPA5 | Human | salubrinal | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | salubrinal results in increased expression of HSPA5 protein | CTD | PMID:24932542 |
HSPA5 | Human | salubrinal | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | salubrinal inhibits the reaction [Rotenone results in increased expression of HSPA5 protein] more ... | CTD | PMID:24932542 more ... |
HSPA5 | Human | salvianolic acid B | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | salvianolic acid B inhibits the reaction [Doxorubicin results in increased expression of HSPA5 protein] | CTD | PMID:28495616 |
HSPA5 | Human | saquinavir | increases expression | EXP | | 6480464 | Saquinavir results in increased expression of HSPA5 protein | CTD | PMID:19147209 |
HSPA5 | Human | SB 203580 | multiple interactions | EXP | | 6480464 | SB 203580 inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein] more ... | CTD | PMID:17341418 more ... |
HSPA5 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of HSPA5 protein | CTD | PMID:37664457 |
HSPA5 | Human | SCH 23390 | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Methamphetamine co-treated with SCH 23390] results in increased expression of HSPA5 mRNA more ... | CTD | PMID:17303341 and PMID:19564919 |
HSPA5 | Human | scopoletin | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Scopoletin results in increased expression of HSPA5 mRNA | CTD | PMID:34979142 |
HSPA5 | Human | scopoletin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Glycochenodeoxycholic Acid co-treated with Scopoletin] results in increased expression of HSPA5 mRNA and [Scopoletin co-treated with Palmitic Acid] results in increased expression of HSPA5 mRNA | CTD | PMID:34979142 |
HSPA5 | Human | selenomethionine | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Selenomethionine inhibits the reaction [T-2 Toxin results in increased expression of HSPA5 mRNA] and Selenomethionine inhibits the reaction [T-2 Toxin results in increased expression of HSPA5 protein] | CTD | PMID:29454614 |
HSPA5 | Human | serpentine asbestos | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Asbestos more ... | CTD | PMID:25324550 |
HSPA5 | Human | serpentine asbestos | increases expression | EXP | | 6480464 | Asbestos more ... | CTD | PMID:25324550 |
HSPA5 | Human | silicon dioxide | affects secretion | EXP | | 6480464 | Silicon Dioxide analog affects the secretion of HSPA5 protein | CTD | PMID:25895662 |
HSPA5 | Human | silicon dioxide | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | erastin promotes the reaction [Silicon Dioxide results in increased expression of HSPA5 protein] | CTD | PMID:37075931 |
HSPA5 | Human | silicon dioxide | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of HSPA5 protein | CTD | PMID:37075931 |
HSPA5 | Human | silicon dioxide | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Silicon Dioxide results in increased expression of HSPA5 protein | CTD | PMID:31028789 |
HSPA5 | Human | silicon dioxide | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Poly G inhibits the reaction [Silicon Dioxide results in increased expression of HSPA5 protein] | CTD | PMID:31028789 |
HSPA5 | Human | silicon dioxide | multiple interactions | EXP | | 6480464 | [Silicon Dioxide analog co-treated with Silver] results in increased expression of HSPA5 mRNA | CTD | PMID:22245057 |
HSPA5 | Human | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide analog results in increased expression of HSPA5 mRNA | CTD | PMID:22245057 |
HSPA5 | Human | silver atom | multiple interactions | EXP | | 6480464 | [Silicon Dioxide analog co-treated with Silver] results in increased expression of HSPA5 mRNA | CTD | PMID:22245057 |
HSPA5 | Human | silver(0) | multiple interactions | EXP | | 6480464 | [Silicon Dioxide analog co-treated with Silver] results in increased expression of HSPA5 mRNA | CTD | PMID:22245057 |
HSPA5 | Human | simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of HSPA5 mRNA and Simvastatin results in increased expression of HSPA5 protein | CTD | PMID:18664198 and PMID:19253821 |
HSPA5 | Human | sirolimus | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Sirolimus co-treated with HRAS protein] results in decreased expression of HSPA5 protein and PPARD protein affects the reaction [[Sirolimus co-treated with HRAS protein] results in decreased expression of HSPA5 protein] | CTD | PMID:24898257 |
HSPA5 | Human | sirolimus | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Sirolimus inhibits the reaction [cadmium acetate results in increased expression of HSPA5 protein] | CTD | PMID:29870746 |
HSPA5 | Human | sirolimus | decreases expression | EXP | | 6480464 | Sirolimus results in decreased expression of HSPA5 mRNA | CTD | PMID:24356939 |
HSPA5 | Human | SKF-96365 hydrochloride | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [Doxorubicin results in increased expression of HSPA5 protein] | CTD | PMID:28495616 |
HSPA5 | Human | SNX-2112 | decreases expression | EXP | | 6480464 | SNX 2112 results in decreased expression of HSPA5 protein | CTD | PMID:23777986 |
HSPA5 | Human | sodium arsenate | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | sodium arsenate results in increased expression of HSPA5 mRNA | CTD | PMID:30953684 |
HSPA5 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of HSPA5 mRNA and sodium arsenite results in decreased expression of HSPA5 protein | CTD | PMID:15899475 and PMID:34032870 |
HSPA5 | Human | sodium arsenite | affects expression | EXP | | 6480464 | sodium arsenite affects the expression of HSPA5 protein | CTD | PMID:34032870 |
HSPA5 | Human | sodium arsenite | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of HSPA5 protein] more ... | CTD | PMID:32506763 and PMID:33241020 |
HSPA5 | Human | sodium arsenite | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | sodium arsenite results in increased expression of HSPA5 protein | CTD | PMID:29459688 and PMID:32593899 |
HSPA5 | Human | sodium arsenite | affects localization | ISO | Hspa5 (Mus musculus) | 6480464 | sodium arsenite affects the localization of HSPA5 protein | CTD | PMID:21911445 |
HSPA5 | Human | sodium arsenite | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of HSPA5 mRNA and sodium arsenite results in increased expression of HSPA5 protein | CTD | PMID:17451858 more ... |
HSPA5 | Human | sodium arsenite | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of HSPA5 protein] | CTD | PMID:21911445 |
HSPA5 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of HSPA5 mRNA and sodium arsenite results in increased expression of HSPA5 protein | CTD | PMID:21925251 more ... |
HSPA5 | Human | sodium chloride | multiple interactions | EXP | | 6480464 | [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of HSPA5 protein more ... | CTD | PMID:38598786 |
HSPA5 | Human | sodium disulfite | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | sodium metabisulfite results in increased expression of HSPA5 protein | CTD | PMID:25486021 |
HSPA5 | Human | sodium fluoride | affects expression | ISO | Hspa5 (Mus musculus) | 6480464 | Sodium Fluoride affects the expression of HSPA5 protein | CTD | PMID:25132241 |
HSPA5 | Human | sodium fluoride | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased expression of HSPA5 protein] and Hesperidin inhibits the reaction [Sodium Fluoride results in increased expression of HSPA5 mRNA] | CTD | PMID:30633982 and PMID:35413380 |
HSPA5 | Human | sodium fluoride | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of HSPA5 protein | CTD | PMID:27548804 |
HSPA5 | Human | sodium fluoride | increases expression | EXP | | 6480464 | Sodium Fluoride results in increased expression of HSPA5 mRNA and Sodium Fluoride results in increased expression of HSPA5 protein | CTD | PMID:24231001 |
HSPA5 | Human | sodium fluoride | multiple interactions | EXP | | 6480464 | Potassium Iodide inhibits the reaction [Sodium Fluoride results in increased expression of HSPA5 mRNA] and Potassium Iodide inhibits the reaction [Sodium Fluoride results in increased expression of HSPA5 protein] | CTD | PMID:24231001 |
HSPA5 | Human | sodium fluoride | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Sodium Fluoride results in increased expression of HSPA5 mRNA and Sodium Fluoride results in increased expression of HSPA5 protein | CTD | PMID:21626649 and PMID:38823497 |
HSPA5 | Human | sodium fluoride | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Sodium Fluoride results in increased expression of HSPA5 mRNA and Sodium Fluoride results in increased expression of HSPA5 protein | CTD | PMID:23707774 more ... |
HSPA5 | Human | sodium fluoride | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Sodium Fluoride affects the expression of HSPA5 mRNA | CTD | PMID:25132241 |
HSPA5 | Human | sorafenib | multiple interactions | EXP | | 6480464 | [sorafenib co-treated with vorinostat] promotes the reaction [FAS protein binds to CASP8 protein binds to ATG5 protein binds to HSPA5 protein] more ... | CTD | PMID:18787411 |
HSPA5 | Human | SR 144528 | multiple interactions | EXP | | 6480464 | [Rimonabant co-treated with SR 144528] inhibits the reaction [Dronabinol results in increased expression of HSPA5 mRNA] | CTD | PMID:31054322 |
HSPA5 | Human | streptozocin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of HSPA5 protein] more ... | CTD | PMID:19634143 more ... |
HSPA5 | Human | streptozocin | increases expression | ISO | Hspa5 (Mus musculus) | 156430337 | streptozocin increases expression of Hspa5 protein in heart | RGD | |
HSPA5 | Human | streptozocin | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Streptozocin results in increased expression of HSPA5 protein | CTD | PMID:30980806 and PMID:38049026 |
HSPA5 | Human | streptozocin | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Dietary Fats co-treated with Streptozocin] results in increased expression of HSPA5 mRNA more ... | CTD | PMID:24967692 more ... |
HSPA5 | Human | streptozocin | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Streptozocin results in increased expression of HSPA5 protein | CTD | PMID:24967692 |
HSPA5 | Human | streptozocin | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Streptozocin results in decreased expression of HSPA5 protein | CTD | PMID:19634143 |
HSPA5 | Human | sulforaphane | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | sulforaphane inhibits the reaction [Streptozocin results in increased expression of HSPA5 protein] | CTD | PMID:24967692 |
HSPA5 | Human | sulfur dioxide | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides]] which results in increased expression of HSPA5 mRNA | CTD | PMID:31268311 |
HSPA5 | Human | sulfur dioxide | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of HSPA5 protein] | CTD | PMID:30503585 |
HSPA5 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of HSPA5 mRNA | CTD | PMID:31533062 |
HSPA5 | Human | surfactin | increases expression | EXP | | 6480464 | surfactin peptide results in increased expression of HSPA5 protein | CTD | PMID:34850538 |
HSPA5 | Human | surfactin C | increases expression | EXP | | 6480464 | surfactin peptide results in increased expression of HSPA5 protein | CTD | PMID:34850538 |
HSPA5 | Human | T-2 toxin | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | salubrinal inhibits the reaction [T-2 Toxin results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:19336499 and PMID:34673134 |
HSPA5 | Human | T-2 toxin | multiple interactions | EXP | | 6480464 | salubrinal inhibits the reaction [T-2 Toxin results in increased expression of HSPA5 mRNA] and salubrinal inhibits the reaction [T-2 Toxin results in increased expression of HSPA5 protein] | CTD | PMID:34673134 |
HSPA5 | Human | T-2 toxin | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | T-2 Toxin results in increased expression of HSPA5 mRNA and T-2 Toxin results in increased expression of HSPA5 protein | CTD | PMID:29454614 and PMID:34673134 |
HSPA5 | Human | T-2 toxin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Selenomethionine inhibits the reaction [T-2 Toxin results in increased expression of HSPA5 mRNA] and Selenomethionine inhibits the reaction [T-2 Toxin results in increased expression of HSPA5 protein] | CTD | PMID:29454614 |
HSPA5 | Human | T-2 toxin | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | T-2 Toxin results in increased expression of HSPA5 mRNA and T-2 Toxin results in increased expression of HSPA5 protein | CTD | PMID:31170431 and PMID:34673134 |
HSPA5 | Human | T-2 toxin | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | T-2 Toxin affects the expression of HSPA5 protein | CTD | PMID:26141394 |
HSPA5 | Human | T-2 toxin | increases expression | EXP | | 6480464 | T-2 Toxin results in increased expression of HSPA5 mRNA and T-2 Toxin results in increased expression of HSPA5 protein | CTD | PMID:31170431 and PMID:34673134 |
HSPA5 | Human | tacrolimus hydrate | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Tacrolimus results in increased expression of HSPA5 mRNA | CTD | PMID:25270620 |
HSPA5 | Human | tamoxifen | multiple interactions | EXP | | 6480464 | Tamoxifen promotes the reaction [Nelfinavir results in increased expression of HSPA5 protein] | CTD | PMID:20594311 |
HSPA5 | Human | tamoxifen | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Tamoxifen inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of HSPA5 protein] and Tamoxifen inhibits the reaction [Dietary Fats results in increased expression of HSPA5 protein] | CTD | PMID:23038002 |
HSPA5 | Human | tamoxifen | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Tamoxifen results in increased expression of HSPA5 mRNA | CTD | PMID:19400957 |
HSPA5 | Human | tamoxifen | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Tamoxifen results in increased expression of HSPA5 mRNA | CTD | PMID:19400957 |
HSPA5 | Human | tamoxifen | affects expression | ISO | Hspa5 (Mus musculus) | 6480464 | Tamoxifen affects the expression of HSPA5 mRNA | CTD | PMID:17555576 |
HSPA5 | Human | tamoxifen | increases expression | EXP | | 6480464 | Tamoxifen results in increased expression of HSPA5 protein | CTD | PMID:19812351 |
HSPA5 | Human | tanespimycin | increases expression | EXP | | 6480464 | tanespimycin results in increased expression of HSPA5 protein | CTD | PMID:16357177 |
HSPA5 | Human | taurine | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Taurine inhibits the reaction [arsenite results in increased expression of HSPA5 protein] | CTD | PMID:25547999 |
HSPA5 | Human | taurodeoxycholic acid | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Taurodeoxycholic Acid inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein] | CTD | PMID:33527851 |
HSPA5 | Human | tauroursodeoxycholic acid | multiple interactions | EXP | | 6480464 | ursodoxicoltaurine inhibits the reaction [Amiodarone results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:12198651 more ... |
HSPA5 | Human | tauroursodeoxycholic acid | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | ursodoxicoltaurine inhibits the reaction [2 more ... | CTD | PMID:25160872 more ... |
HSPA5 | Human | tauroursodeoxycholic acid | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | ursodoxicoltaurine results in increased expression of HSPA5 protein | CTD | PMID:25160872 |
HSPA5 | Human | tauroursodeoxycholic acid | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA] and ursodoxicoltaurine inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein] | CTD | PMID:20165829 and PMID:29027487 |
HSPA5 | Human | tebufenpyrad | increases expression | EXP | | 6480464 | 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of HSPA5 mRNA | CTD | PMID:33512557 |
HSPA5 | Human | telmisartan | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | telmisartan results in decreased expression of HSPA5 protein | CTD | PMID:19102871 |
HSPA5 | Human | TEMPO | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | TEMPO inhibits the reaction [nickel sulfate results in increased expression of HSPA5 mRNA] and TEMPO inhibits the reaction [nickel sulfate results in increased expression of HSPA5 protein] | CTD | PMID:28296042 |
HSPA5 | Human | tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of HSPA5 mRNA | CTD | PMID:12766906 |
HSPA5 | Human | testosterone | affects expression | ISO | Hspa5 (Mus musculus) | 6480464 | Testosterone affects the expression of HSPA5 mRNA | CTD | PMID:17003280 |
HSPA5 | Human | testosterone | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Testosterone deficiency results in decreased expression of HSPA5 mRNA | CTD | PMID:33848595 |
HSPA5 | Human | tetrachloromethane | affects expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride affects the expression of HSPA5 mRNA | CTD | PMID:15963342 |
HSPA5 | Human | tetrachloromethane | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of HSPA5 mRNA and Carbon Tetrachloride results in increased expression of HSPA5 protein | CTD | PMID:31150632 and PMID:33779329 |
HSPA5 | Human | tetrachloromethane | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea inhibits the reaction [Carbon Tetrachloride results in increased expression of HSPA5 mRNA] and STF 083010 inhibits the reaction [Carbon Tetrachloride results in increased expression of HSPA5 protein] | CTD | PMID:25827057 and PMID:30538632 |
HSPA5 | Human | tetrachloromethane | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of HSPA5 mRNA and Carbon Tetrachloride results in increased expression of HSPA5 protein | CTD | PMID:25827057 more ... |
HSPA5 | Human | tetrachloromethane | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of HSPA5 mRNA more ... | CTD | PMID:20097184 more ... |
HSPA5 | Human | thapsigargin | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Thapsigargin results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:12198651 more ... |
HSPA5 | Human | thapsigargin | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Thapsigargin results in increased expression of HSPA5 mRNA and Thapsigargin results in increased expression of HSPA5 protein | CTD | PMID:14610226 more ... |
HSPA5 | Human | thapsigargin | increases expression | EXP | | 6480464 | Thapsigargin results in increased expression of HSPA5 mRNA and Thapsigargin results in increased expression of HSPA5 protein | CTD | PMID:12147617 more ... |
HSPA5 | Human | thapsigargin | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Thapsigargin results in increased expression of HSPA5 more ... | CTD | PMID:16236328 more ... |
HSPA5 | Human | thapsigargin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Thapsigargin results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:17915553 more ... |
HSPA5 | Human | thapsigargin | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | [Thapsigargin co-treated with HRAS protein] results in increased expression of HSPA5 protein more ... | CTD | PMID:17475668 more ... |
HSPA5 | Human | Theaflavin 3,3'-digallate | multiple interactions | EXP | | 6480464 | [Methotrexate co-treated with theaflavin-3 and 3'-digallate] results in decreased expression of HSPA5 protein | CTD | PMID:34350509 |
HSPA5 | Human | Theaflavin 3,3'-digallate | decreases expression | EXP | | 6480464 | theaflavin-3 and 3'-digallate results in decreased expression of HSPA5 protein | CTD | PMID:34350509 |
HSPA5 | Human | thiamethoxam | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Thiamethoxam results in increased expression of HSPA5 mRNA and Thiamethoxam results in increased expression of HSPA5 protein | CTD | PMID:33533595 |
HSPA5 | Human | thioacetamide | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of HSPA5 mRNA and Thioacetamide results in increased expression of HSPA5 protein | CTD | PMID:33677747 and PMID:34492290 |
HSPA5 | Human | thiostrepton | increases expression | EXP | | 6480464 | Thiostrepton results in increased expression of HSPA5 mRNA | CTD | PMID:22321511 |
HSPA5 | Human | thiram | increases expression | EXP | | 6480464 | Thiram results in increased expression of HSPA5 mRNA | CTD | PMID:38568856 |
HSPA5 | Human | thymoquinone | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [thymoquinone results in increased expression of HSPA5 protein] | CTD | PMID:29981725 |
HSPA5 | Human | thymoquinone | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | thymoquinone inhibits the reaction [Doxorubicin results in increased expression of HSPA5 protein] | CTD | PMID:34392583 |
HSPA5 | Human | thymoquinone | increases expression | EXP | | 6480464 | thymoquinone results in increased expression of HSPA5 mRNA and thymoquinone results in increased expression of HSPA5 protein | CTD | PMID:29981725 |
HSPA5 | Human | Tiron | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:23892647 |
HSPA5 | Human | titanium dioxide | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of HSPA5 mRNA and titanium dioxide results in increased expression of HSPA5 protein | CTD | PMID:23557971 more ... |
HSPA5 | Human | titanium dioxide | decreases methylation | ISO | Hspa5 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of HSPA5 gene and titanium dioxide results in decreased methylation of HSPA5 promoter | CTD | PMID:35295148 |
HSPA5 | Human | titanium dioxide | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased expression of HSPA5 mRNA] and 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased expression of HSPA5 protein] | CTD | PMID:31298478 |
HSPA5 | Human | toluene | increases expression | EXP | | 6480464 | Toluene results in increased expression of HSPA5 protein | CTD | PMID:12183065 |
HSPA5 | Human | toluene | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Toluene results in increased expression of HSPA5 mRNA | CTD | PMID:22967744 |
HSPA5 | Human | transplatin | decreases expression | EXP | | 6480464 | transplatin results in decreased expression of HSPA5 mRNA | CTD | PMID:11099651 |
HSPA5 | Human | triadimefon | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | triadimefon results in decreased expression of HSPA5 mRNA | CTD | PMID:16643972 |
HSPA5 | Human | tributylstannane | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [tributyltin results in increased expression of HSPA5 protein] more ... | CTD | PMID:23743301 |
HSPA5 | Human | tributylstannane | decreases expression | EXP | | 6480464 | tributyltin results in decreased expression of HSPA5 mRNA | CTD | PMID:27678064 |
HSPA5 | Human | tributylstannane | increases expression | EXP | | 6480464 | tributyltin results in increased expression of HSPA5 protein | CTD | PMID:23743301 |
HSPA5 | Human | Tributyltin oxide | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | bis(tri-n-butyltin)oxide results in increased expression of HSPA5 mRNA | CTD | PMID:22434021 |
HSPA5 | Human | trichloroethene | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Trichloroethylene results in decreased expression of HSPA5 mRNA | CTD | PMID:15363585 |
HSPA5 | Human | trichloroethene | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of HSPA5 mRNA | CTD | PMID:33387578 |
HSPA5 | Human | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of HSPA5 mRNA | CTD | PMID:24935251 |
HSPA5 | Human | trichostatin A | affects expression | EXP | | 6480464 | trichostatin A affects the expression of HSPA5 mRNA | CTD | PMID:28542535 |
HSPA5 | Human | triclocarban | increases expression | EXP | | 6480464 | triclocarban results in increased expression of HSPA5 mRNA and triclocarban results in increased expression of HSPA5 protein | CTD | PMID:30592132 |
HSPA5 | Human | triclosan | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Triclosan results in increased expression of HSPA5 mRNA | CTD | PMID:36277366 |
HSPA5 | Human | triclosan | decreases expression | EXP | | 6480464 | Triclosan results in decreased expression of HSPA5 mRNA | CTD | PMID:34681664 |
HSPA5 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of HSPA5 mRNA | CTD | PMID:37042841 |
HSPA5 | Human | triphenyl phosphate | multiple interactions | EXP | | 6480464 | CD36 protein affects the reaction [triphenyl phosphate results in increased expression of HSPA5 protein] | CTD | PMID:38450882 |
HSPA5 | Human | triphenyl phosphate | increases expression | EXP | | 6480464 | triphenyl phosphate results in increased expression of HSPA5 protein | CTD | PMID:38450882 |
HSPA5 | Human | triphenylstannane | increases expression | EXP | | 6480464 | triphenyltin analog results in increased expression of HSPA5 protein | CTD | PMID:31634547 |
HSPA5 | Human | Triptolide | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | triptolide results in decreased expression of HSPA5 protein | CTD | PMID:26990902 |
HSPA5 | Human | Triptolide | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | triptolide results in increased expression of HSPA5 mRNA and triptolide results in increased expression of HSPA5 protein | CTD | PMID:27022166 and PMID:36520315 |
HSPA5 | Human | Triptolide | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | STING1 protein affects the reaction [triptolide results in increased expression of HSPA5 protein] more ... | CTD | PMID:36520315 |
HSPA5 | Human | triptonide | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | triptonide results in decreased expression of HSPA5 mRNA | CTD | PMID:33045310 |
HSPA5 | Human | troglitazone | affects response to substance | EXP | | 6480464 | HSPA5 protein affects the susceptibility to troglitazone | CTD | PMID:15525695 |
HSPA5 | Human | troglitazone | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | troglitazone results in decreased expression of HSPA5 mRNA | CTD | PMID:25596134 |
HSPA5 | Human | troglitazone | increases expression | EXP | | 6480464 | Troglitazone results in increased expression of HSPA5 mRNA and Troglitazone results in increased expression of HSPA5 protein | CTD | PMID:15525695 more ... |
HSPA5 | Human | tunicamycin | multiple interactions | EXP | | 6480464 | Bortezomib inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein] more ... | CTD | PMID:16357177 more ... |
HSPA5 | Human | tunicamycin | multiple interactions | ISO | Hspa5 (Mus musculus) | 401842386 | naltrexone inhibits the reaction [tunicamycin increases expression of Hspa5 mRNA in liver] | RGD | |
HSPA5 | Human | tunicamycin | increases expression | ISO | Hspa5 (Mus musculus) | 401842386 | tunicamycin increases expression of Hspa5 mRNA in liver | RGD | |
HSPA5 | Human | tunicamycin | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Tunicamycin results in increased expression of HSPA5 mRNA and Tunicamycin results in increased expression of HSPA5 protein | CTD | PMID:15019097 more ... |
HSPA5 | Human | tunicamycin | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Tunicamycin results in increased expression of HSPA5 mRNA and Tunicamycin results in increased expression of HSPA5 protein | CTD | PMID:15049342 more ... |
HSPA5 | Human | tunicamycin | increases expression | EXP | | 6480464 | Tunicamycin results in increased expression of HSPA5 mRNA and Tunicamycin results in increased expression of HSPA5 protein | CTD | PMID:12147617 more ... |
HSPA5 | Human | tunicamycin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA] more ... | CTD | PMID:18477628 more ... |
HSPA5 | Human | tunicamycin | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 3-N-1(spermine)-7 more ... | CTD | PMID:20015086 more ... |
HSPA5 | Human | U-73122 | multiple interactions | EXP | | 6480464 | 1-(6-((3-methoxyestra-1 more ... | CTD | PMID:33421459 |
HSPA5 | Human | umbelliferone | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | 7-hydroxycoumarin results in increased expression of HSPA5 mRNA | CTD | PMID:34979142 |
HSPA5 | Human | umbelliferone | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | [7-hydroxycoumarin co-treated with Palmitic Acid] results in increased expression of HSPA5 mRNA | CTD | PMID:34979142 |
HSPA5 | Human | uranium atom | increases expression | EXP | | 6480464 | Uranium results in increased expression of HSPA5 mRNA | CTD | PMID:14971665 |
HSPA5 | Human | ursodeoxycholic acid | decreases expression | EXP | | 6480464 | Ursodeoxycholic Acid results in decreased expression of HSPA5 mRNA | CTD | PMID:24312631 |
HSPA5 | Human | ursolic acid | increases expression | EXP | | 6480464 | Ursolic Acid results in increased expression of HSPA5 protein | CTD | PMID:24802810 |
HSPA5 | Human | ursolic acid | multiple interactions | EXP | | 6480464 | 1 more ... | CTD | PMID:24802810 and PMID:36587836 |
HSPA5 | Human | usnic acid | multiple interactions | EXP | | 6480464 | [usnic acid co-treated with Lipopolysaccharides] results in decreased expression of HSPA5 mRNA | CTD | PMID:22777745 |
HSPA5 | Human | valproic acid | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Valproic Acid results in increased expression of HSPA5 protein | CTD | PMID:16236328 |
HSPA5 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of HSPA5 mRNA | CTD | PMID:23179753 more ... |
HSPA5 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of HSPA5 mRNA | CTD | PMID:25979313 |
HSPA5 | Human | valproic acid | affects expression | ISO | Hspa5 (Mus musculus) | 6480464 | Valproic Acid affects the expression of HSPA5 mRNA | CTD | PMID:17292431 |
HSPA5 | Human | vanillic acid | multiple interactions | EXP | | 6480464 | Vanillic Acid inhibits the reaction [INS protein results in increased expression of HSPA5 protein] | CTD | PMID:36764371 |
HSPA5 | Human | vemurafenib | multiple interactions | EXP | | 6480464 | [KRAS protein mutant form affects the susceptibility to vemurafenib] which results in increased expression of HSPA5 protein | CTD | PMID:27222248 |
HSPA5 | Human | vildagliptin | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Vildagliptin inhibits the reaction [Dietary Fats results in increased expression of HSPA5 protein] | CTD | PMID:34081941 |
HSPA5 | Human | vinclozolin | decreases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of HSPA5 mRNA | CTD | PMID:15686871 and PMID:23034163 |
HSPA5 | Human | vincristine | increases expression | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Vincristine results in increased expression of HSPA5 mRNA | CTD | PMID:33038355 |
HSPA5 | Human | vincristine | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Quercetin inhibits the reaction [Vincristine results in increased expression of HSPA5 mRNA] | CTD | PMID:33038355 |
HSPA5 | Human | vitamin E | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | Vitamin E inhibits the reaction [pyrazole results in increased expression of HSPA5 protein] | CTD | PMID:18068688 |
HSPA5 | Human | vitexin | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | vitexin inhibits the reaction [APP protein modified form results in decreased expression of HSPA5 mRNA] | CTD | PMID:29545167 |
HSPA5 | Human | vorinostat | multiple interactions | EXP | | 6480464 | [sorafenib co-treated with vorinostat] promotes the reaction [FAS protein binds to CASP8 protein binds to ATG5 protein binds to HSPA5 protein] more ... | CTD | PMID:18787411 |
HSPA5 | Human | wortmannin | multiple interactions | EXP | | 6480464 | wortmannin inhibits the reaction [Thapsigargin results in increased expression of HSPA5 mRNA] | CTD | PMID:19428936 |
HSPA5 | Human | xylitol | increases expression | EXP | | 6480464 | Xylitol results in increased expression of HSPA5 protein | CTD | PMID:32275922 |
HSPA5 | Human | xylitol | multiple interactions | EXP | | 6480464 | ursodoxicoltaurine inhibits the reaction [Xylitol results in increased expression of HSPA5 protein] | CTD | PMID:32275922 |
HSPA5 | Human | Z-Val-Phe-H | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | calpain inhibitor III inhibits the reaction [deoxynivalenol results in increased degradation of HSPA5 protein] | CTD | PMID:19336499 |
HSPA5 | Human | zearalenone | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Zearalenone results in increased expression of HSPA5 protein | CTD | PMID:30394307 and PMID:31982503 |
HSPA5 | Human | zearalenone | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | 2-aminoethyl diphenylborinate inhibits the reaction [Zearalenone results in increased expression of HSPA5 protein] and 4-phenylbutylamine promotes the reaction [Zearalenone results in increased expression of HSPA5 protein] | CTD | PMID:30394307 and PMID:31982503 |
HSPA5 | Human | zinc atom | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Zinc inhibits the reaction [lead acetate binds to HSPA5 protein] | CTD | PMID:10702365 |
HSPA5 | Human | zinc atom | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of HSPA5 mRNA | CTD | PMID:18593933 |
HSPA5 | Human | zinc oxide | increases expression | ISO | Hspa5 (Mus musculus) | 6480464 | Zinc Oxide analog results in increased expression of HSPA5 mRNA | CTD | PMID:25680694 |
HSPA5 | Human | zinc pyrithione | increases expression | EXP | | 6480464 | pyrithione zinc results in increased expression of HSPA5 mRNA | CTD | PMID:21424779 |
HSPA5 | Human | zinc(0) | multiple interactions | ISO | Hspa5 (Rattus norvegicus) | 6480464 | Zinc inhibits the reaction [lead acetate binds to HSPA5 protein] | CTD | PMID:10702365 |
HSPA5 | Human | zinc(0) | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of HSPA5 mRNA | CTD | PMID:18593933 |
HSPA5 | Human | zoledronic acid | increases expression | EXP | | 6480464 | zoledronic acid results in increased expression of HSPA5 mRNA | CTD | PMID:25596134 |
HSPA5 | Human | zoledronic acid | decreases expression | EXP | | 6480464 | Zoledronic Acid results in decreased expression of HSPA5 mRNA and Zoledronic Acid results in decreased expression of HSPA5 protein | CTD | PMID:35587103 |